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Zusammenfassung  
(Oberflächen-) Gewässer weltweit sind mit geringen Mengen (ng/L bis wenige µg/L) 
humaner Pharmazeutika belastet. Diclofenac (DCF; nicht-steroidal, entzündungshemmend) 
und Metoprolol (MTP; ß-Blocker) gehören entsprechend ihres hohen Verbrauchs zu den am 
häufigsten gefundenen Substanzen. Deren biologische Aktivität ist nicht auf den Menschen 
beschränkt. Gut konservierte Enzyme innerhalb der Vertebraten legen Auswirkungen auf 
Nicht-Zielorganismen wie Fische nahe, die bisher in Langzeituntersuchungen mit 
umweltrelevanten Konzentrationen unzureichend untersucht wurden. In der vorliegenden 
Arbeit wurden die physiologischen Effekte von DCF und MTP auf die Nil-Tilapie 
(Oreochromis niloticus), einem der wichtigsten Aquakulturfische weltweit, untersucht. In 
vitro konnte anhand primärer Hepatozyten gezeigt werden, dass bereits umweltrelevante 
Konzentrationen von DCF zu einer erhöhten Genexpression verschiedener Schlüsselenzyme 
der Detoxifizierung führten. Nach MTP-Exposition waren die Veränderungen weniger 
eindeutig. Beide Substanzen induzierten die Vitellogenin Genexpression, nur DCF jedoch 
bereits in umweltrelevanter Konzentration. In vivo wurden in zwei Langzeit-
Expositionsversuchen die physiologischen Effekte vom befruchteten Ei bis 80 Tage nach 
Schlupf in O. niloticus untersucht. Beide Substanzen hatte keinen Einfluss auf Schlupferfolg 
und Überleben, das Wachstum war nach 80 Tagen nach Schlupf leicht reduziert. Die 
deutlichsten Auswirkungen waren histopathologische Veränderungen der Kiemen, veränderte 
Genexpressionen der Gonadotropine und eine erhöhte Expression von Vitellogenin. Die 
Ergebnisse legen eine stärkere östrogene Aktivität von DCF im Vergleich zu MTP nahe. 
Zusammenfassend sind die Bedenken gegenüber den Einzelsubstanzen eher gering, negative 
Auswirkungen auf die Reproduktion und sich verstärkende Effekte bei zeitgleicher Exposition 
gegenüber DCF und MTP lassen sich jedoch nicht ausschließen und sollten im Weiteren 
untersucht werden.  
 
 
Schlagwörter: Pharmazeutika, Diclofenac, Metoprolol, Nil-Tilapie, primäre Hepatozyten, 
Langzeitexposition, populationsrelevante Endpunkte, Kiemen Histopathologie, 
Detoxifizierung, Gonadotropine, östrogene Aktivität 
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Summary 
Surface waters worldwide are contaminated with low levels (ng/L up to few µg/L) of human 
pharmaceuticals. Diclofenac (DCF; non-steroidal, anti-inflammatory) and metoprolol (MTP; 
ß-blocker) are highly consumed and therefore commonly detected. Their biological activity is 
not restricted to humans. Well conserved enzymes within the vertebrates suggest effects on 
non-target organisms such as fish, poorly studied in long-term exposure experiments using 
environmentally relevant concentrations. In the presented work, physiological effects of DCF 
and MTP on the Nile tilapia (Oreochromis niloticus), an important aquaculture fish species, 
were studied. Using primary hepatocytes, it was shown in vitro that environmentally relevant 
concentrations of DCF increased the gene expression of different key enzymes of the 
detoxification, while MTP exposure had a less clear effect. Both substances induced 
vitellogenin gene expression, but only after DCF exposure this was significantly elevated 
already at the environmentally relevant concentration. In vivo, two long-term exposure 
studies on the physiological effects from the fertilized egg until 80 days post-hatch were 
evaluated. Both substances did not affect hatching success and survival, while growth was 
slightly reduced after 80 days post-hatch. Histopathological alterations of the gills, changed 
gene expression patterns of the gonadotropins and induced vitellogenin gene expression were 
the most dominant findings. The results indicate a stronger estrogenic mode of action of DCF 
compared to MTP. Overall, the risk due to a single substance exposure seems to be relatively 
low but adverse effects on reproduction and additive effects during simultaneous exposure to 
DCF and MTP cannot be excluded and should be investigated further.  
 
Keywords: pharmaceuticals, diclofenac, metoprolol, Nile tilapia, primary hepatocytes, long-
term exposure, general parameters, gill histopathology, detoxification, gonadotropins, 
estrogenic activity 
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1 Introduction 
At present, hardly any freshwater ecosystem exists which is not directly or indirectly affected 
by human activities. With the progress of industrialization and the steady increase in the 
world´s population, human-induced stressors to aquatic ecosystems and the organisms living 
therein, increased. Encroachments range from structural changes of surface waters such as 
river straightening for vessel traffic to changes in the chemical composition of the water 
bodies. These can be due to accidental or intentional releases of liquid and solid waste 
products. Aquatic systems functioned as sinks for anthropogenic pollutants ever since and 
hence show a huge diversity of contaminants (Fent 2003). Besides growing industry, the 
increasing input of nutrients and chemicals can also be attributed to the growing agricultural 
sector, including aquaculture. Therefore, human pharmaceuticals, veterinary medical 
compounds and a large number of pesticides is frequently found in surface waters but also in 
ground water and occasionally even in drinking water (Heberer 2002; Fent et al. 2006). 
Aquatic organisms are likely impaired, since they are exposed throughout their life cycles, 
and as a feedback mechanism, humans might be as well when consuming aquatic organisms 
(Fent 2003).  
1.1 Pharmaceuticals and their endocrine disruption potential 
The occurrence of human pharmaceuticals and their metabolites in aquatic ecosystems is of 
growing international concern. A great variety of pharmaceuticals has already been detected 
in wastewater effluents, surface waters and ground waters in the range of ng L
-1
 to a few  
µg L
-1
 (Halling-Sørensen et al. 1998; Fent et al. 2006), adding up to more than 100 different 
substances in the environment so far (Monteiro and Boxall 2010). Some highly consumed 
pharmaceuticals were even spotted in drinking water, e.g. diclofenac (DCF) (up to 6 ng L
-1
) 
and ibuprofen (3 ng L
-1
) (Jones et al. 2005). An increasing, often uncontrolled overuse of 
pharmaceuticals is one main explanation and the consumption of pain killers such as DCF is 
predicted to further grow (as reviewed by Schröder et al. 2016). Furthermore, many human 
pharmaceuticals are metabolized only partly or excreted largely unmodified from the ingested 
drugs and hence low levels of the active compounds are continuously discharged. On a global 
scale, sewage treatment plants (STPs) are the major route of the release of pharmaceuticals 
into aquatic ecosystems (e.g. Kolpin et al. 2002, US; Andreozzi et al. 2003, Europe; Ashton et 
al. 2004, UK) (Figure 1). Unfortunately, conventional technologies in STPs often do not 
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sufficiently remove these compounds that are mainly excreted by urine or faeces (Ternes 
1998; Daughton and Ternes 1999; Ferrari et al. 2003). Additionally, veterinary and even 
human pharmaceuticals can be discharged due to the distribution of liquid manure and sewage 
sludge on agricultural areas and end up in the ground water, too. There is a compulsive 
assessment of the environmentally relevant characteristics for newly introduced veterinary 
drugs since 1994 and for human ones since 1998. But foodstuff often contains additives such 
as antibiotics that are classified as growth promoters and therefore are subjected to the 
'Foodstuffs, consumer goods and animal feed' code and not mandatory pass through 
ecotoxicological testing (Fent 2003).  
 
 
Figure 1. Anticipated exposure routes of pharmaceutically active compounds (PhACs) in the 
environment (modified from Halling-Sørensen et al. 1998). Highlighted in red is the approach of this 
work. 
 
Pharmaceuticals are developed to modify certain physiological processes in humans but are 
not restricted to that (Halling-Sørensen et al. 1998). The occurrence of pharmaceuticals in 
aquatic ecosystems is well documented (Huschek et al. 2004; Fent et al. 2006) but little is 
known about their effects on non-target species in the environment (Fent et al. 2006, Ericson 
et al. 2010). According to Han et al. (2010), most investigations on pharmaceutical toxicity to 
non-target species are limited to lethal effects during acute exposure. Acute toxicities of 
selected human pharmaceuticals were determined using standardized tests with bacteria, algae 
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and crustaceans (Farré et al. 2001; Ferrari et al. 2003; Cleuvers 2004) or some fish species, 
mainly Japanese medaka (Oryzias latipes) and rainbow trout (Oncorhynchus mykiss) (Fent et 
al. 2006). Halling-Sørensen et al. (1998) stated almost two decades ago that many 
pharmaceuticals do not possess an acute aquatic toxicity due to low actual concentration 
ranges in the environment but significant cumulative effects on the metabolism of non-target 
organisms occur. Nonetheless, chronic toxicity tests are limited, maybe due to the complex 
experimental work (Santos et al. 2010). In general, acute toxicity challenges use orders of 
magnitude higher concentrations compared to chronic studies. Triebskorn et al. (2004, 2007) 
found the lowest observed effect concentration (LOEC) of different pharmaceuticals in 
rainbow trout to be 1 µg L
-1
, and therefore in the environmentally relevant range. Effective 
concentrations based on acute toxicity tests range around 100 mg L
-1
 (Fent et al. 2006). 
Therefore, the scientific discussion emphasizes the risk of misinterpretations of physiological 
impacts on aquatic organisms based on acute toxicity testing and stresses out the urgent need 
of chronic exposure studies (Hoeger et al. 2005; Fent et al. 2006; Triebskorn et al. 2007), 
hardly implemented until today. The topicality even increased recently, since three 
pharmaceuticals, including DCF, were added to the EU's pollutant 'watch list' of emerging 
aquatic pollutants of the Water Framework Directive (Decision 2015/495). Data on possible 
adverse effects in the aquatic biota, especially fish, is needed as a basis for a refined risk 
assessment. 
 
Potential long-term ecotoxicological effects can be the accumulation of compounds in the 
aquatic organism (bioaccumulation),  the promotion of antibiotic resistances, gene activation 
and silencing, changes of the immunological status and disturbances in the hormonal 
homeostasis (endocrine disruption). Ethinylestradiol (EE2), the potent synthetic estrogen used 
in contraceptive pills, is one of the most popular and alarming examples of pharmaceuticals in 
the aquatic environment. It is likely to cause feminization or even more harassing, seems to be 
responsible for the collapse of a fathead minnow (Pimephales promelas) population in a lake 
experimentally enriched with that substance (Kidd et al. 2007).  
 
Endocrine changes of normal (fish) physiology due to endocrine disrupting chemicals (EDCs) 
are a great concern in ecotoxicology. EDCs are defined as 'exogenous substances or mixtures 
that alter function(s) of the endocrine system and consequently cause adverse health effects in 
an intact organism or its progeny or (sub)populations' (WHO 2002). These substances can be 
of natural or synthetic (man-made) origin (Reif et al. 2010). Since hormones control a number 
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of physiological functions such as development, growth, metabolism, reproduction and 
behavior (Norris and Carr 2013), disruptions of this system can cause severe changes. The 
mode of actions of EDCs are as diverse as the compounds themselves and include effects on 
hormone biosynthesis, release into circulation, blood plasma transportation as well as 
metabolism and excretion (Tyler et al. 1998; Vos et al. 2000; Sanderson 2006; Cheshenko et 
al. 2008). Additionally, some EDCs disrupt hormonal signaling by mimicking, blocking or 
modulating the interactions of endogenous hormones with their receptors (Sonnenschein and 
Soto 1998; Zoeller 2005; Tilghman et al. 2010). Concerning EDCs, alterations of the 
reproductive systems with emphasis on (anti)estrogenic and (anti)androgenic modes of 
actions are studied most intense so far (e.g. Jobling et al. 1998, 2006, 2009). Nonetheless, 
changes in the stress hormone system (Pottinger 2003), thyroid system (Jugan et al. 2010; 
Lorenz et al. 2011), immune system (Chalubinski and Kowalski 2006; Inadera 2006) as well 
as obesity and metabolic disorders (Desvergne et al. 2009; Gruen and Blumberg 2006) are 
under investigation.  
1.2 Test substances  
Overall, the diversity of therapeutic compounds is huge, but five major groups were defined 
(Heberer 2002): i) analgesics and anti-inflammatory drugs, ii) antibiotics, iii) antiepileptic 
drugs, iv) ß-blockers and v) blood lipid regulators. Non-steroidal anti-inflammatory drugs 
(NSAIDs) and ß-blockers are among the most frequently detected pharmaceuticals in aquatic 
ecosystems (Jones et al. 2002; Huschek et al. 2004) since they belong to the most prescribed 
classes of pharmaceuticals. They are continuously consumed and furthermore often resistant 
to biodegradation (Ternes 1998; Heberer 2002; Andreozzi et al. 2003). DCF and metoprolol 
(MTP), the two model substances used in the experiments presented, belong to these two 
groups of pharmaceuticals.  
1.2.1 Diclofenac 
Diclofenac (DCF, Figure 2) is a NSAID used to treat inflammatory reaction and pain such as 
back pain, migraine or pain due to fever in human and veterinary medicine (Zhang et al. 
2008). Like acetylsalicylic acid or ibuprofen, DCF is sold over the counter. It is applied 
worldwide but records for many developing countries are unclear since no consistent data 
recording exists. In Germany, annual DCF consumption is around 90 t per year. Therefore, 
DCF belongs to the 15 most often sold drugs (Huschek et al. 2004). Estimates predict that 
70 % of the consumed DCF are excreted without any modification via urine into the water 
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cycle, which accounts for 63 t annually (Meißner 2008). DCF is very persistent in the aquatic 
environment and shown to be incompletely subjected to catabolism during the passage 
through conventional STPs. Therefore, DCF was detected in concentrations of ng L
-1
 to low 
µg L
-1 
in sewage waters and consequently in surface waters around the world (e.g. Ternes 
1998; Stumpf et al. 1999; Heberer 2002; Ashton et al. 2004; Gómez et al. 2007; Letzel et al. 
2009). Stumpf et al. (1999) published the first record of DCF in the aquatic environment in 
1999 and a few years later, DCF and ibuprofen were detected in drinking water in Germany at 
low ng L
-1
 concentrations (Heberer 2002). In Italy, about 5 µg L
-1
 were measured in 
wastewater effluents (Andreozzi et al. 2003).  
 
 
Figure 2. Chemical structure of DCF. 
 
In humans, DCF inhibits the cyclooxygenases (COX-1 und COX-2), enzymes generally 
conserved across vertebrates (Grosser et al. 2002). COX enzymes catalyze the production of 
inflammatory prostaglandins and if they are inhibited,  no such compounds are produced. 
Prostaglandins regulate a large number of physiological processes ranging from 
thermoregulation, water balance, glomerular filtration and homeostasis to control of ovulation 
(Fujimori et al. 2011). In fish, prostaglandins are essential for the reproduction, since they can 
influence the ovulation and spawning behavior as well as the oocyte maturation (Goetz et al. 
1989). The prostaglandin E2 (PGE2) is involved in fish ovulation and might be regulated by 
COX-2 (Fujimori et al. 2011). Therefore, NSAIDs might cause reproductive impairments by 
disrupting the production of PGE2 due to COX-2 inhibition. Furthermore, Díaz-Cruz et al. 
(2005) showed in their study about breast cancer in humans that cyclooxygenase inhibitors 
lead to a decreased expression of aromatase mRNA. Aromatase is the key enzyme for the 
conversion of testosterone to 17ß-estradiol (E2). The latter is essential for the gonadal 
differentiation and therefore sexual differentiation in fish (D'Cotta et al. 2001). Al-Qutob and 
Nashashibi (2009) demonstrated that feeding early developmental stages of Nile tilapia 
(Oreochromis niloticus) with DCF containing feedstuff lead to a later impairment of their 
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reproduction. Therefore, DCF might have modulatory effects on the regulation of 
reproduction in Nile tilapia. 
 
In different studies negative impacts of low but environmentally relevant DCF concentrations 
on the physiology of rainbow trout and Japanese medaka were demonstrated (Schwaiger et al. 
2004; Triebskorn et al. 2004, 2007; Hong et al. 2007; Cuklev et al. 2011; Lee et al. 2011). The 
LOEC of DCF in fish was set to be 1 µg L
-1
 (Triebskorn et al. 2004),  leading to increasing 
public concern. Most studies were conducted with trout species since they are easy to 
maintain under experimental conditions and occur in freshwater and seawater environments. 
The authors showed that the exposure to concentrations as low as 1 µg L
-1
 DCF caused 
pathological changes in the liver tissue in rainbow trout and at 5 µg L
-1
 DCF severe 
morphological changes in the tissues of kidney and gills appeared. Memmert et al. (2013) 
conducted one of the few studies combining population relevant endpoints and 
histopathological effects in rainbow trout (Oncorhynchus mykiss) and zebrafish (Danio rerio) 
after DCF exposure. The authors concluded that DCF has most likely no adverse effect up to 
320 µg L
-1 
DCF. In fact, a significant decrease in survival was found in early life stages of 
carp (Cyprinus carpio) only after exposure to 3 mg L
-1
 DCF for 30 days (Stepanova et al. 
2013). Nonetheless, pharmaceuticals have the potential to act as endocrine disrupting 
compounds (EDC) (Kloas et al. 2009; Massarsky et al. 2011) and it was shown recently that 
DCF has a potential estrogenic endocrine activity already at environmentally relevant 
concentrations in fish hepatocytes in vitro (Gröner et al. 2015) and in vivo (Hong et al. 2007) 
as well as in amphibians (Efosa in prep., pers. comm.). 
1.2.2 Metoprolol 
Metoprolol (MTP, Figure 3) belongs to the therapeutic class of ß-adrenergic receptor 
antagonists, shortly ß-blockers. It binds to the ß-adrenoreceptors (ß-ARs) and blocks their 
actions. ARs are a class of G protein-coupled receptors building the adrenergic system. This 
regulates many aspects of vertebrate metabolism and function. Endogenous catecholamine 
hormones, epinephrine and norepinephrine, are the messengers and their binding stimulates 
the sympathetic nervous system, helping the organism to respond to physical, environmental 
and behavioral stressors (Wendelaar-Bonga 1997). Norepinephrine mainly acts as a neural 
transmitter substance with a localized effect while epinephrine possess systemic effects 
leading to an increased performance. Two AR types with different subtypes are distinguished. 
Briefly, the α-ARs with the main subtypes α1 and α2 use calcium (Ca
2+
) as a second 
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messenger. The α1-receptor regulates the muscle cell contraction and the α2-type in the 
noradrenergic neurons the inhibition of transmitter release. Binding of epinephrine elevates 
the cytosolic concentration of cyclic adenosine monophosphate (cAMP) by activating the 
adenylyl cyclase, an enzyme converting ATP to cAMP (Campbell and Reece 2002). The 
cAMP then activates another protein, usually the protein kinase A and it is the main second 
messenger of the ß-ARs. Three different subtypes are commonly distinguished. The ß1-typ is 
found in the heart and kidney tissue. It is influencing the heart rate, contractility and stimulus 
conduction in the heart and the release of the enzyme renin in the kidneys. The ß2-typ mainly 
occurs in the liver, stimulating glycogenolysis. The ß3-typ is located in the brown adipose 
tissue and it is associated with lipolysis and thermogenesis (Held et al. 2013).  
 
MTP binds specific to ß1-receptors and is therefore used to treat cardiovascular diseases like 
hypertension, heart arrhythmia or heart attack (Regårdh et al. 1974). In Germany, more than 
90 t are sold annually and therefore MTP is, like DCF, one of the top-selling drugs (Huschek 
et al. 2004). MTP was detected in surface waters in concentrations up to 2.2 µg L
-1 
(Ternes 1998). Information about the degradation rates of ß-blockers in STPs vary between  
0-96 % (Ternes 1998; Andreozzi et al. 2003).   
 
 
Figure 3. Chemical structure of MTP. 
 
The adrenergic system is well-conserved in all vertebrates, including fish. Massarsky et al. 
(2011) could show that binding kinetics of fish and mammalian ß-ARs are quite similar and 
concluded that drugs affecting mammalian ARs will also affect fish species. According to 
Santos et al. (2010), ß-ARs can be found in the heart, liver and gonads of fish and hence there 
is a great probability that chronic exposures to ß-blockers lead to negative impacts in these 
non-target organisms. So far, only little information about the effects of MTP on the 
physiology of aquatic organisms is published (Liu and Williams 2007). Triebskorn et al. 
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(2007) conducted one of the rare studies on the effects of MTP on fish. They showed that 
concentrations as low as 1 µg L
-1
 affected the liver, but also kidney and gills of rainbow trout 
in various ways. The LOEC for damages to liver cells was found to be 1 µg L
-1
 and to gills to 
be 20 µg L
-1
. Owen et al. (2007) could show that ß-blockers influence the development and 
reproduction in fish. They can lead to a delay in the embryonic development and evoke 
changes in plasma levels of sex hormones. Huggett et al. (2002) showed that MTP caused a 
decrease in testosterone in male medaka and a significant increase in E2 in both sexes. They 
supposed an increase in aromatase activity as a possible reason but did not verify it.  
1.3 Fish as model organism in ecotoxicology 
Fish, like all aquatic organisms, are exposed to numerous pollutants present in the aquatic 
environment throughout their lifetime. As fish share many physiological functions with 
humans, they also have many drug targets in common (Gunnarsson et al. 2008) and even 
common detoxification pathways may occur. Therefore, fish is a useful model organism to 
study the effects of human pharmaceuticals and their metabolites in surface waters. In 
contrast, aquatic invertebrates and plants lack many of these common drug targets. 
Nonetheless, many standard risk assessments are performed with crustaceans and algae but 
the transferability of these test results to predict effects in fish is rather questionable. For 
example, data on effects of estrogenic substances from invertebrates, that lack an estrogen 
receptor, cannot be used to predict estrogenic effects in fish which possess estrogen receptors 
(Gunnarsson et al. 2012). Furthermore, fish are a taxonomic diverse group with around 
32,000 extant species (www.fishbase.org) adapted to different environmental conditions. 
Hence, extrapolations between fish species should be based on species-specific molecular 
knowledge (Celander 2011).  
1.4 Physiological responses 
Physiology is the study of the functions of an organism (Campbell and Reece 2002). As a 
consequence of a changing environment, organisms are forced to adapt to new conditions 
permanently. Three steps are usually involved in the physiological response of an organism to 
environmental conditions: (i) signal reception, (ii) signal transduction and (iii) (cellular) 
response. In the last stage, the signal triggers a specific cellular activity such as catalysis by an 
enzyme or activation of specific genes. Overall, this helps to ensure that crucial activities 
occur in the right cells, at the right time, and are well coordinated with the other cells of the 
organism (Campbell and Reece 2002), resulting in a proper adaptation to the outer conditions. 
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Physiological responses can be measured at different levels. Taking growth as an example, 
this can be measured directly by evaluating length and weight or rather indirectly by using 
specific biomarkers indicating growth. These in turn can be evaluated on the protein level in 
serum or at the gene expression level in their main synthesizing tissues.  
1.4.1 Growth regulation  
Growth in fish, like in all vertebrates, is under genetic control but also influenced by 
environmental factors such as temperature and food availability. These external stimuli and 
internal physiological conditions are merged and processed in the brain via the hypothalamus-
pituitary axis and then further relayed to the target organs (Figure 4). The hypothalamus 
produces antagonistic polypeptides, growth hormone-releasing hormone and growth 
hormone-inhibiting hormone or somatostatin. The pituitary then produces growth hormone 
(GH) regulated by the hypothalamic hormones. GH binds to its receptors in the target organs, 
mainly the liver. There it stimulates the synthesis and release of the insulin-like growth factor 
I (IGF-I). Both, GH and IGF-I are transported bound to specific binding proteins in the blood 
circulation. IGF-I is involved in almost all processes responsible for somatic growth, 
including regulation of protein, lipid, carbohydrate and mineral metabolism in the cells as 
well as cell differentiation and proliferation. All these functions are mediated by IGF 
receptors. Besides the liver as the main producer for IGF-I, a variety of other tissues such as 
brain, muscle, kidney and gut produce IGF-I locally (Moriyama et al. 2000).  
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Figure 4. Schematic diagram of the endocrine regulation of growth in vertebrates, including fish. 
Growth hormone releasing hormone (GHRH) stimulates (+), while somatostatin (SST) inhibits (-) the 
release of hypophyseal growth hormone (GH). Attached to GH binding protein, GH circulates in the 
blood stream to the liver and induces the synthesis and release of insulin-like growth factor I (IGF-I), 
the main stimulator of somatic growth in target tissues (modified after Moriyama et al. 2000). 
 
1.4.2 Detoxification mechanisms 
The occurrence of xenobiotics, i.e. foreign substances, in aquatic ecosystems is especially 
important since the affected organisms cannot escape from the continuous exposure. In fish, 
two pathways exist for xenobiotics to enter the body. Waterborne chemicals can directly enter 
the fish via its openings and/or contaminated food can be ingested (Streit 1998). Different 
responses to xenobiotics evolved related to the chemical nature of the compounds and 
scientists use them as biomarkers for early detection and assessment of impacts of pollutants. 
They developed such biomarkers as a tool to study pollution-induced variations in biological 
systems (Peakall 1992), which are often related to detoxification processes. Their production 
is regulated by receptors that can recognize xenobiotics and different types of proteins work 
together. This increases the ability to excrete the xenobiotics and prevent harmful 
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accumulation in the body. The main target organ is the liver, where xenobiotics but also 
endogenous compounds such as steroid hormones are metabolized (Waxman et al. 1988, 
Parkinson 1996). Some exogenous chemicals are excreted largely unmodified but the majority 
is detoxified during a biotransformation process (Figure 5). Biotransformation is defined as 
the transformation of chemical compounds in an organisms (Parkinson 1996). The 
biotransformation processes consist of a range of proteins and are characterized by different 
phases. During phase I and II, biotransformation enzymes are active, while efflux pumps are 
working in phase 0 or III (Xu et al. 2005). Overall, fat-soluble substances are metabolized to 
more water-soluble compounds that can be excreted more easily from the body.  
 
 
Figure 5. Pathways of biotransformation of xenobiotics in fish (modified from van Leeuwen and 
Hermens 1995). 
 
In more detail (Figure 6), during phase I oxidation occurs to increase the polarity and 
therefore the water solubility of the xenobiotics, mainly catalyzed by the cytochrome P450 
(CYP) system. This system is essential for the biotransformation of contaminants and the 
CYP1A subfamily is the most important one with regard to biotransformation and 
bioactivation of xenobiotics. In general, many xenobiotics induce the de novo synthesis of 
cytochrome P450 proteins in fish. The enzymes metabolize, among others, exogenous 
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compounds such as food additives and drugs. They are mainly found in the liver but various 
other tissues such as kidney, heart and gills exhibit them too (Goksøyr and Husøy 1998). 
CYP1A is known to be involved in the metabolism of many environmental contaminants in 
fish (e.g. polycyclic aromatic hydrocarbons; van der Oost et al. 2003) but exposure to a range 
of pharmaceuticals (including clofibrate, DCF and carbamazepine) often revealed CYP1A 
inhibition or no effect (e.g. Laville et al. 2004; Thibaut et al. 2006). Only few studies could 
demonstrate an induction of CYP1A activity (e.g. Laville et al. 2004; Hong et al. 2007; 
Gröner et al. 2015). Subsequently, during phase II, conjugation of the compounds with either 
glutathione, sulfate, amino acids or glucuronic acid occurs (Goodman Gilman et al. 1990). 
These reactions are catalyzed by different transferases. Electrophilic compounds are 
conjugated by the glutathione S-transferase (GST) and nucleophilic ones by the glucuronyl 
transferase. Water solubility and excretability further increase. Finally, the modified 
compounds are transported and excreted by efflux pumps. These are membrane proteins, 
actively transporting a wide range of compounds out of the cells. They belong to the large 
superfamily of ATP-binding cassette (ABC) proteins (Leslie et al. 2005). Their prominent 
members are the permeability glycoprotein (P-gp) and the related multidrug resistance protein 
(MDRP). The gene coding for P-gp is denoted ABCB1 and for MDRP is ABCC. P-gps are 
involved in the transport of un-metabolized xenobiotics in phase 0, while MDRPs protect 
tissues from xenobiotic-induced damage by transporting mainly conjugated metabolites 
(phase III) (Leslie et al. 2001). Fish excrete via bile, urine and gills (Nimmo 1987; Clarke et 
al. 1991). It has been suggested that phase I-III enzymes are regulated in a coordinated way, 
resulting in a high protection level of cells from xenobiotic damage (Bard 2000; Leslie et al. 
2005). 
 
 
Figure 6. Biotransformation pathway in a liver cell. CYP1A: cytochrome P4501A monooxygenase, 
GST: glutathione-S-transferase, MDRP: multidrug resistance protein, Pgp: permeability glycoprotein. 
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1.4.3 Oxidative stress 
Oxidative stress is defined as a disruption of the pro-antioxidative balance, meaning the 
generation and removal of radical species within an organism is imbalanced. These radical 
species mainly involve oxygen and are referred to as reactive oxygen species (ROS). ROS 
overwhelm the cellular defenses and damage proteins, membranes and DNA (Kelly et al. 
1998). Many xenobiotics likely enhance the production of ROS and therefore lead to 
oxidative damage (Winston and Di Giulio 1991; Oruç 2010). Different antioxidative enzymes 
for the detoxification of ROS exist in all organisms. The most important enzymes are 
superoxide dismutase, catalase (CAT) and glutathione peroxidase. Changes in their activity 
are often used as biomarkers of pollutant-mediated oxidative stress (Winston and Di Giulio 
1991). Another mean of measuring the toxic consequences of oxidative stress is to evaluate 
the effects at the subcellular level including lipid peroxidation (LPO). LPO is probably the 
most extensively studied process induced by free radicals (De Zwart et al. 1999). A direct 
measurement of the endogenous primary LPO products is difficult and therefore secondary 
oxidation products are analyzed. The most often used assay for LPO is the thiobarbituric acid 
reactive substance (TBARS) test. During this test, a colored adduct from the reaction of LPO 
products and thiobarbituric acid (TBA), mainly malondialdehyde (MDA), is produced. Since 
TBA also reacts with other oxidation products the test is nonspecific and only a rough 
measure (Kelly et al. 1998). 
1.4.4 Regulation of reproduction  
Similar to growth regulations, reproduction in all vertebrates is under endocrine control. 
Internal (e.g. nutritional status) and external stimuli (e.g. photoperiod and temperature), 
influencing the central nervous system, are processed by the hypothalamus-pituitary gonad 
(HPG) axis, regulating reproduction (Norris and Carr 2013).  
 
Briefly, gonadotropin-releasing hormones (GnRHs) are the main neuropeptides produced by 
neuroendocrine cells of the hypothalamus stimulating the synthesis and secretion of the 
pituitary gonadotropins, namely luteinizing hormone (LH) and follicle stimulating hormone 
(FSH). LH and FSH regulate cell differentiation, proliferation and steroidogenesis of gonad 
tissue (Lubzens et al. 2010; Schulz et al. 2010), leading to the production and release of sex 
steroids (androgens, estrogens and progesterone). Finally, the sex steroids affect target cells 
and cause feedback mechanisms on hypothalamus and pituitary (Figure 7). 
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Figure 7. Schematic diagram of endocrine regulation of sex steroids in fish by the hypothalamus-
pituitary-gonad (HPG) axis. Hypothalamic gonadotropin-releasing hormone (GnRH) stimulates the 
synthesis and release of pituitary gonadotropins, namely luteinizing hormone (LH) and follicle 
stimulating hormone (FSH). The gonadotropins stimulate the synthesis and release of sex steroids in 
the gonads and these can cause negative feedbacks on hypothalamus and pituitary. Circulating sex 
steroids (estradiol: E2; testosterone: T; 11-ketotestosterone: 11-KT) affect target cells. Shown is for 
instance the effect of E2 in liver cells, inducing vitellogenin (VTG) synthesis and influencing sex 
differentiation and egg maturation. arom: aromatase (catalyzes the conversion of T into E2); ER: 
estrogen receptor; SBP: sex hormone binding proteins.  
 
LH and FSH consist of two subunits, a common glycoprotein-hormone α-subunit and a 
specific β-subunit and their biological activity is mediated by a membrane-bound G-protein 
coupled receptor (Levavi-Sivan et al. 2010). While FSH most likely stimulates early 
development of the ovarian follicle and spermatogenesis in the testis, LH is influencing the 
final gamete maturation leading to ovulation in females and spermiation in males (Levavi-
Sivan et al. 2010; Lubzens et al. 2010; Schulz et al. 2010). Gonadotropins are key hormones 
of the reproduction but their effects are rather indirect via stimulation of sex steroid synthesis 
and local growth factors in the gonads (Kloas et al. 2009; Lubzens et al. 2010; Schulz et al. 
2010). Sex steroids are essentially important for different reproductive processes including 
vitellogenesis (Lubzens et al. 2010), spermatogenesis (Schulz et al. 2010), final maturation of 
gametes and ovulation as well as spermiation (Nagahama and Yamashita 2008; Scott et al. 
2010), expression of secondary sexual characteristics (Borg 1994) and reproductive behavior 
(Munakata and Kobayashi 2010). Furthermore, they modulate physiological functions such as 
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metabolism (Mauvais-Jarvis 2011) and the immune system (Vainikka et al. 2004; Gilliver 
2010). In fish, the predominant androgen is 11-ketotesterone, while testosterone and 
dihydrotestosterone can be found in all higher vertebrates (Tinsley and Kobel 1996; Kloas et 
al. 2009). Two main signal transduction pathways are mediating the actions of sex steroids. 
They act via nuclear receptors directly activating transcriptional cascades (Aranda and 
Pascual 2001; Björnström and Sjöberg 2005) or they bind to membrane-associated steroid 
receptors, initiating non-genomic steroid actions (Thomas et al. 2006; Hammes and Levin 
2007).  
 
Sex steroids regulate gonadotropin synthesis and secretion via feedback mechanisms on the 
hypothalamus and pituitary (Zohar et al. 2010), leading to permanent adjustments of the 
activity of the HPG axis and maintenance of the homeostasis of the organism (Kloas and Lutz 
2006). Positive and negative feedback effects of sex steroids on the synthesis and release of 
LH and FSH in fish have been reported (e.g. Huggard-Nelson et al. 2002). 
1.5 The model species Oreochromis niloticus  
O. niloticus (Nile tilapia, Figure 8) is a teleost fish belonging to the order of Perciformes 
(perch-like) and the family of Cichlidae (cichlids). It is native to tropical and subtropical 
Africa and widely distributed in the Nile and Niger river basin. O. niloticus is living 
preferable in shallow waters at temperatures of 31-36 °C, but can withstand a huge 
temperature range of 12 - 42 °C. It is an omnivorous grazer and relatively resistant to poor 
water quality, indicated by its occurrence in sewage canals or irrigation channels 
(Bailey 1994). Sexual maturity is reached at three to six months depending on the 
temperature. In general, reproduction occurs at temperatures higher than 20 °C. Breeding is 
feasible all year around (asynchronous breeder) and the females incubate the eggs in their 
mouth and brood the fry after hatching until the yolk sac is absorbed. This is called maternal 
mouth breeding (FAO 2016).  
 
 
Figure 8. Oreochromis niloticus, Nile Tilapia. 
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Tilapia (including all species) is the second most important group of farmed fish and therefore 
of high economical value (Figure 9, FAO 2016). It is frequently cultured in net cages of 
surface waters with great potential to be contaminated by environmental pollutants, including 
pharmaceuticals such as DCF. The main producer countries are China and Egypt, followed by 
Indonesia, Thailand and Brazil, countries all having hardly any wastewater treatment and only 
insufficient environmental regulations. Since Nile tilapia is easy to grow all year round it is 
repeatedly used in toxicological research (Costa et al. 2012).  
 
 
 
Figure 9. Global aquaculture production of Oreochromis niloticus (tones) (1950-2015). Source: FAO 
Fish Stat. 
 
1.6 Aim of the study 
The occurrence of human pharmaceuticals in aquatic ecosystems has been well documented 
in recent years. However, little is known about ecotoxicological effects due to chronic 
exposure on non-target organisms such as fish. These are particularly important, since fish 
cannot escape from the continuous exposure. Aim of the study was to investigate the effects 
of two commonly found substances belonging to two different therapeutic classes of drugs, 
DCF and MTP, on Nile tilapia (O. niloticus). Exposure concentrations ranged from 
environmentally relevant to 100-fold thereof. Nile tilapia is one of the most important 
aquaculture fish species worldwide. The cultivation of aquaculture fish in contaminated water 
is likely to occur in many tropical countries where open aquaculture systems (net cages) are 
used. Overall, the ability of DCF and MTP to alter the expression of selected genes in the 
liver was investigates in vitro and in vivo. Additionally, population relevant responses 
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integrated with molecular biological and histological endpoints were assessed in two 
identically designed long-term exposure experiments (80 days post-hatch) in vivo.  
 The following working hypotheses were established:  
 
In vitro exposure of O. niloticus to DCF or MTP in the range of 4x10
-9
 M to 4x10
-7
 M 
(environmentally relevant up to 100-fold higher) 
 
(1) affects detoxification mechanisms in liver cells by inducing biotransformation phase I 
to III enzymes, indicated by an increase in gene expression of CYP1A, GST and 
MDRP. 
(2) induces vitellogenin gene expression, indicating the potential estrogenic mode of 
action. 
 
In vivo exposure of O. niloticus to DCF or MTP in the range of 4x10
-10
 M to 4x10
-7
 M 
(environmentally relevant up to 100-fold higher) 
 
(3) has most likely no negative effects on the general parameters hatching and survival 
but adverse impacts on growth parameters, including altered gene expression of 
hypophyseal GH and hepatic IGF-I. 
(4) causes adverse alterations of the gills, one of the first barrier organ in exposed fish, 
expressed by histopathological changes.  
(5) affects biomarkers associated with endocrine activity concerning gonadotropin gene 
expression (LH, FSH) and estrogenicity (VTG). The potential estrogenic mode of 
action is indicated by an increase of VTG gene expression. 
(6) affects detoxification mechanisms in liver and gill tissue by inducing 
biotransformation phase I to III enzymes, indicated by an increase in gene expression 
of CYP1A, GST and MDRP. 
(7) is likely to cause oxidative stress in various organs of fish based on elevated TBARS 
levels. 
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2 Materials and methods 
2.1 Chemicals  
All chemicals were obtained from Sigma Aldrich (Steinheim, Germany) or as indicated 
otherwise. DCF sodium salt and MTP tartrate (Table 1) were dissolved in Milli-Q-grade 
water. EE2 (CAS: 57-63-6) with a purity of >98 % was dissolved in ethanol (p.a.) and 
substances were used for exposure stock preparation to reveal final test concentrations. 
 
Table 1. Main physical-chemical properties of the tested substances. 
 Diclofenac (sodium salt) Metoprolol (tartrate) 
therapeutic class anti-inflammatory ß-blocker 
CAS number 15307-79-6 56392-17-7 
molecular weight (g mol
-1
) 318.13 684.82 
formula C14H11Cl2NO2 · NaCl (C15H25NO3)2 · C4H6O6 
purity >98 % >98 % 
Log Kow 0.57 1.69 
solubility (mg L
-1
) 50,000 50,000 
 
2.2 Experimental animals 
2.2.1 In vitro experiments 
Male Nile tilapia (O. niloticus), weighing between 100-200 g, were obtained from the stock of 
Leibniz-Institute of Freshwater Ecology and Inland Fisheries, Berlin, Germany. Prior to cell 
isolation, fish were kept in an aerated 800 L tank with water flow-through (26 ± 1 °C, natural 
photoperiod) for several weeks and fed daily ad libitum with a commercial fish food (Aller 
Aqua Primo, Golßen, Germany).  
2.2.2 In vivo experiments 
Fertilized eggs of O. niloticus were collected from the permanent brood stock of the Leibniz-
Institute of Freshwater Ecology and Inland Fisheries. No acclimation of eggs was conducted. 
Eggs were placed directly into the experimental set-up to reflect natural conditions were eggs 
are immediately exposed to environmental pollutions after release. The experiments were run 
in accordance with the local animal welfare committee (LaGeSo G 0276/12). 
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2.3 Primary hepatocytes – in vitro experiments 
2.3.1 Primary hepatocyte isolation 
Hepatocytes were isolated according to the method described by Schmid et al. (2000) with 
slight modification. Briefly, fish were anesthetized by immersion in tricaine methanesulfonate 
(MS222; 8 g L
-1
, Sigma, Germany) and injected with heparin (3000 U dissolved in 0.6 mL 
water; Roth, Karlsruhe, Germany). Perfusion of liver, carried out at room temperature, was 
performed retrogradly by inserting a catheter (1 mm diameter) via the bulbus arteriosus into 
the heart. First, calcium-magnesium free (CMF) medium (100 mL, Table 2) was used to wash 
out blood. Next, tissue was digested for approximately 20 min with calcium-magnesium 
containing (CMC) medium (50 mL, Table 2), supplemented with collagenase D and H 
(0.25 mg mL
-1
 each; Roche, Mannheim, Germany). The liver was then perfused with 50 mL 
CMF medium and removed from the body cavity. Finally, the liver was transferred into ice-
cold CMF medium and to receive a dispersed cell solution minced with a scalpel. The cell 
suspension was filtered through meshes of 250 and 50 µm, centrifuged (4 °C, 70 g for 5 min, 
50 g for 5 min, 30 g for 5 min) and the resulting cell pellet was resuspended in minimum 
essential medium (MEM, Table 2). Cell density was counted using a Neubauer chamber. 
Hepatocytes were seeded at a density of 1 x 10
6
 cells mL
-1
 MEM in sterile culture discs 
(35 mm diameter) and incubated overnight at 20 °C under normal air conditions in an 
incubator (Heraeus, Hanau, Germany).   
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Table 2. Composition of media used for perfusion and culture of Oreochromis niloticus primary 
hepatocytes (according to Schmid et al. 2000). CMF: calcium-magnesium free medium, CMC: 
calcium-magnesium containing medium, MEM: minimal essential medium. 
 CMF CMC MEM 
NaCl (mM) 142 142 142 
KCl (mM) 5.4 5.4 5.4 
CaCl2 (mM) - 2.4 2.4 
MgSO4*7H2O (mM) - - 0.81 
Na2HPO4 (mM) 0.42 0.42 0.42 
KH2PO4 (mM) 0.44 0.44 0.44 
NaHCO3 (mM) 0.43 - 0.43 
HEPES (mM) 15 15 20 
amino acids (50x) (mL/L) - - 20 
vitamins (100x) (mL/L) - - 20 
NaEDTA (mM) 5 - - 
glutamine (mM)* 1 - - 
Media were adjusted to pH 7.5 and 1 mL per 100 ml medium of a penicillin-streptomycin solution 
(10,000 units penicillin and 10 mg streptomycin per mL) and glutamine* were added after sterile 
filtration and immediately before use. Amino acids, vitamins and glutamine were obtained from PAN 
Biotech (Aidenbach, Germany). 
2.3.2 Hepatocyte treatment 
Following overnight culture without exposure to chemicals, hepatocytes were exposed to test 
substances for 24 h (Table 3) for target gene transcription analyses. MEM was changed every 
12 h and 2/3 of the culture medium including test substance concentrations were replaced 
twice. EE2 was included as a positive control for VTG induction (for concentrations, see 
Table 3); MEM-only was used as control. After 24 h of exposure, culture medium was 
removed and 700 µL Trizol (Invitrogen, Darmstadt, Germany) was added. Cells were 
harvested and immediately frozen in liquid nitrogen and stored at -80 °C until further 
analysis. 
 
Table 3. Experimental design of Oreochromis niloticus primary hepatocyte in vitro exposure to DCF, 
MTP and ethinylestradiol (EE2). 
 Control Diclofenac Metoprolol EE2 
[M] 0 4x10
-9
 4x10
-8
 4x10
-7
 4x10
-9
 4x10
-8
 4x10
-7
 10
-6
 
[µg L
-1
] 0 1.27 12.72 127.24 1.07 10.69 106.94 0.3 
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2.4 Flow-through system – in vivo long-term exposure  
2.4.1 Experimental set-up 
Long-term exposure experiments were run in a temperature controlled continuous flow-
through system (FTS) to maintain constant exposure conditions for the duration of the 
experiments. Two in vivo experiments were conducted, identical in experimental design, but 
with two different pharmaceuticals in the exposure medium, namely DCF and MTP. 
 
The FTS consists of a water preparation unit providing artificial fresh water (AFW) and of a 
water bath equipped with a maximum of sixty-four 9 L glass aquaria (30 x 20 x 14.5 cm). 
Four glass aquaria are clustered (Figure 10), receiving exposure medium from a common 
mixing chamber. Using a peristaltic pump, stock solutions are continuously dosed into the 
mixing chambers with constant temperature controlled AFW inlet, regulated by a rotameter. 
The resulting exposure medium flows directly into the cluster of four replicate test aquaria per 
test concentration (140 mL min
-1
 ± 5 %). Stock solutions were renewed every fourth day and 
stored in light-protected glass bottles. The flow rate was set to at least 50 L exposure medium 
per tank and day, which means a water exchange rate of about seven tank volumes per day. 
AFW flow rates were measured once per week, stock solution flow rates were adjusted daily. 
Each tank was aerated and temperature was set to 27 ± 1 °C. The photoperiod was 
12 h light to 12 h dark. 
 
 
Figure 10. Experimental set-up in the flow-through system, showing one cluster (one treatment) 
including the different rearing devices. 
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AFW consists of analytical grade salts dissolved in Milli-Q- grade water. Reconstituted water 
then passed through several filters (5, 1, 0.5, 0.45 µm) to remove particulate material, a UV-
sterilizer and a final particle filter (Lutz et al. 2008). Water temperature, pH and dissolved 
oxygen were recorded every working day using a portable multimeter (HQ40d multi, Hach 
Lange GmbH, Düsseldorf, Germany).  Nutrients (NH4
+
, NO2
-
, NO3
-
, PO4
3-
) were measured 
once per week in one tank per cluster. To maintain water quality, tanks were cleaned 
regularly. Biofilm accumulating on the inner surfaces of the aquaria was scraped off and 
detritus was siphoned from the tanks.  
 
The FTS was operated one week prior to egg transfer to insure substance concentrations of 
demand. Eggs (24 per tank) were carefully transferred into the glass aquaria filled with 7L of 
exposure medium. No acclimation phase was included into the experimental design to reflect 
natural conditions where eggs are immediately exposed to environmental pollution. Special 
incubation devices (Figure 11) were constructed providing permanent movement of the eggs 
by air bubbles, simulating the maternal care procedure. Therefore, a sieve was mounted on a 
vertically adjustable rack and an air stone was placed beyond each device to ensure slight 
movement of the eggs. After yolk sack adsorption free swimming larvae were released into a 
breeding container placed into the tank and when all larvae were free swimming and feeding, 
larvae were released into the entire glass aquarium. Stainless steel meshes kept juvenile fish 
back in the aquaria. Free-feeding fish were fed at least four times per day with a commercial 
dry food (Aller Artex). 
 
   
Figure 11. Breeding device. Nile tilapia are mouth breeders and this device fulfilled the tasks of 
maternal care, permanent movement of the eggs, by air bubbles to ensure constant supply of fresh 
water enriched with oxygen (for reason of visibility, the air stone was switched off to take these 
pictures). 
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Nominal test concentrations were measured weekly by quadrupole time-of-flight liquid 
chromatography/mass spectrometry (Q-TOF LC/MS) throughout the entire experiment (see 
'DCF and MTP extraction and analyses' for details). Waste waters were disposed through an 
activated-charcoal filter in order to remove the exposure chemicals from the water to prevent 
for contaminations of the environment.  
2.4.2 Experimental design 
For both test substances, four nominal concentrations and a control group were included into 
the experimental design (Table 4). Test concentrations were chosen according to 
concentrations found in the environment, with the two lowest test concentrations approaching 
the environmental concentrations. The experiment was run for 80 days post-hatch (dph) and 
sampling was performed after 8, 30 and 80 dph. Depending on the fish size different 
parameters were recorded and analyzed (Table 5). 
 
Table 4. Experimental design of long-term exposure experiments in the flow-through system. 
 Diclofenac Metoprolol 
[M] 0 4x10
-10
 4x10
-9
 4x10
-8
 4x10
-7
 0 4x10
-10
 4x10
-9
 4x10
-8
 4x10
-7
 
[µg L
-1
] 0 0. 13 1.27 12.72 127.24 0 0.11 1.07 10.69 106.94 
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Table 5. Summary of sampling and endpoints according to the developmental stages. dph: days post 
hatch, CYP1A: cytochrome P4501A monooxygenase, GST: glutathione-S-transferase, MDRP: 
multidrug resistance protein, LH: luteinizing hormone, FSH: follicle stimulating hormone, GH: growth 
hormone, IGF-I; insulin-like growth factor I, VTG: vitellogenin, TBARS: thiobarbituric acid 
substances. 
Sampling points/  
endpoints 
prehatch 8 dph  
(larvae) 
 
30 dph  
(juvenile) 
80 dph  
(adult) 
hatching rate X    
survival  X X X 
morphological  
length [mm]  X X X 
wet weight [g]  X X X 
gill histology    X 
molecular biological  
CYP1A  X X X 
GST  X X X 
MDRP  X X X 
LH    X 
FSH    X 
GH    X 
IGF-I    X 
VTG    X 
TBARS    X 
 
2.4.3 DCF and MTP extraction and analyses 
Effective pharmaceutical concentrations were analyzed in duplicates weekly using Q-TOF 
LC/MS. Exposure medium samples (200 mL) were removed from one tank per cluster and 
concentrated using solid phase extraction with C18 cartridges. Cartridges were prepared by 
filling 500 mg octadecyl (Bakerbond, 40 µm Prep LC), enclosed by two PTFE frits 
(Bakerbond) into glass columns (Bakerbond spe 7328-06; J.T. Baker, Germany).  Methanol 
(HPLC-MS grade) and formic acid (LC-MS grade) were obtained from Roth and Fluka, 
respectively. Cartridges were preconditioned and equilibrated with methanol and Milli-Q-
water, 5 mL each. After passing the exposure media of each treatment, cartridges were dried 
under nitrogen. Elution of substances was achieved with methanol (3 x 2 mL). Afterwards 
samples were concentrated to dryness at 40 °C under nitrogen using a rotary evaporator 
(Büchi R-200 with heating bath B-490, Flawil, Switzerland) combined with a vacuum pump 
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(ILMVAC, Ilmenau, Germany). Samples were re-dissolved in 1 mL methanol. Control 
samples and samples of 4x10
-10
 M were measured directly; the others had to be diluted with 
methanol + 0.1 % formic acid (4x10
-9
 M  1:5, 4x10
-8
 M 1:50, 4x10
-7
 M 1:500). DCF and MTP 
concentrations of water samples were determined by Q-TOF LC/MS. Details of the applied 
methods are provided in the annex.  
2.4.4 Tissue sampling 
For both in vivo experiments, all fish were sampled within one day at the time of sampling. 
Fish were anaesthetized using ice water bath and killed by spinal transection. Growth 
parameters of each individual fish were recorded. Different tissue samples were taken in the 
following order: first and second right gill arches were dissected and immediately frozen in 
liquid nitrogen. For gill histology the third left gill arches of experimental fish were dissected 
and transferred into embedding cassettes and fixed in Bouin´s solution (Sigma, Germany) for 
24 h. Samples were transferred to EtOH (70 %), the EtOH solution was renewed two times 
(after 24 h) and storage was conducted in EtOH (70 %) until further processing. 
 
Brain and pituitary samples were taken and immediately frozen in liquid nitrogen. 
Furthermore liver and muscle samples were taken and immediately frozen in liquid nitrogen 
as well. Frozen samples were stored at -80 °C until further processing.   
2.4.5 General parameters 
2.4.5.1 Hatching 
Hatching of larvae was recorded daily. Percentage of hatching success was calculated by 
dividing the number of hatched larvae by the number of inserted eggs.  
2.4.5.2 Growth 
Fish total body length (tip of mouth to end of tail fin) and body wet weight were measured for 
every individual fish. Length was determined using a caliper rule to the nearest mm and wet 
weight to the nearest mg using a balance (Sartorius, Göttingen, Germany).  Parameters were 
analyzed on a tank replicate basis to reduce the impact of individual outliers. The arithmetic 
mean and standard deviation of the mean values of the four replicates per treatment were 
calculated.  
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2.4.5.3 Morphological indices 
Different morphological indices were calculated to have some indication about nutritional 
status (Futon´s condition index, CI) and degree of pollution (hepatosomatic index, HSI) of 
test organisms: 
CI [g/cm³] = wet weight [g] x 100 / (length)
3
 [cm] (according to Fulton 1904) 
HSI [%] = (liver weight [g] / wet weight [g]) x 100 
2.4.5.4 Survival 
Mortality was recorded daily. Mortality rates were calculated by dividing the number of dead 
fish by the initial number of larvae hatched. Fish removed during sampling were not 
considered. Survival rates (%) were calculated by subtracting mortality rates from 100.  
2.4.6 Gene expression analyses 
Samples obtained from in vitro and in vivo experiments were subjected to gene expression 
analyses. Chemicals and reagents used for gene expression analyses are listed in Table 6. 
 
Table 6. Chemicals and reagent kits used for gene expression analyses (listed in the order of usage). 
Chemicals/reagent kits Details/description Supplier 
2-mercaptoethanol 99 % p.a. Roth, Karlsruhe, Germany 
RNeasy Plus Micro kit buffer RLT Plus (lysis buffer, contains a 
guanidine salt); Buffer RW1 (contains a 
guanidine salt and EtOH); Buffer RPE  
(washing buffer, concentrate); RNase free 
water; spin columns 
Qiagen, Hilden, Germany 
ethanol (EtOH) >99 % p.a. or diluted with nuclease free 
water  
Roth, Karlsruhe, Germany 
nuclease free water sterile, tested and certified to be free of 
DNase and RNase activity 
VWR, Darmstadt, Germany 
Trizol Reagent contains phenol and guanidine 
isothiocyanate 
Invitrogen, Darmstadt, 
Germany 
chloroform ≥ 99 % p.a. Roth, Karlsruhe, Germany 
isopropanol 2-propanol, ≥ 99.8 % p.a. Roth, Karlsruhe, Germany 
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Table 6. Continued. 
RNA 6000 Nano kit RNA Nano chips; RNA-ladder (0.2, 0.5, 
1.0, 2.0, 4.0, 6.0 kb length); RNA marker; 
RNA dye concentrate (5x); gel matrix; 
spin filters 
Agilent Technologies, 
Waldbronn, Germany 
DNase I kit (amplification grade) 10x DNase I reaction buffer; DNase I 
enzyme (1U/µL); EDTA (25 mM) 
Invitrogen, Darmstadt, 
Germany 
AMV-RT kit AMV-RT buffer (10x); AMV-RT enzyme 
(2500 U) 
Biozym, Hess. Oldendorf, 
Germany 
poly(dt) primer PCR grade; 0.1 nM µL
-1
 stock solution; 
sequence: 
CCTGAATTCTAGAGCTCA(T)17 
Biometra, Göttingen, Germany 
dNTPs PCR grade, 10 mM each Qiagen, Hilden, Germany 
MMLV-RT kit MMLV-RT buffer (10x); DTT (100 mM); 
MMLV-RT enzyme (200 U/µL) 
Biozym, Hess. Oldendorf, 
Germany 
platinum Taq DNA polymerase 
kit 
10x PCR Buffer (-MgCl2), MgCl2 
(50 mM), Platinum Taq Polymerase (5U/ 
µL) 
Invitrogen, Darmstadt, 
Germany 
SYBR Green solution DNA dye, concentrate (10000x) in 
DMSO; used 1:200 diluted 
Invitrogen, Darmstadt, 
Germany 
agarose gel Gel for electrophoresis, with ethidium 
bromide (10 mg/mL) 
Invitrogen, Darmstadt, 
Germany 
TAE-buffer 1x  (pH: 8.5, 20 mM Tris–HCl, 0.1 % 
acetic acid (p.a.), and 1 mM NaEDTA) 
Roth, Karlsruhe, Germany 
bromphenolblue buffer loading dye: 100 µL glycerin, 99 µL 
nuclease free water, 1 µL bromphenolblue 
 
QIAquick gel extraction kit silica-membrane-based purification of 
DNA fragments from gels (cleanup of up 
to 10 μg DNA (70 bp to 10 kb)); PB buffer 
contains guanidine hydrochloride and 2-
propanol, PE buffer (1x) diluted with 
EtOH (100 %) to (5x) 
Qiagen, Hilden, Germany 
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2.4.6.1 RNA extraction 
Depending on the amount of tissue available, the protocol of total RNA extraction varied. 
Extraction of total RNA from pituitary was carried out using the RNeasy Plus Micro 
extraction kit while all other samples were processed by Trizol Reagent extraction.  
 
Extraction of total RNA from pituitary 
Pituitary tissue was extracted using Qiagen RNeasy Micro kit including on-column DNase 
digestion according to the manufacturer´s protocol. All working steps were conducted at room 
temperature. Briefly, 2-mercaptoethanol was added to the lysis buffer (RLT buffer) before 
starting. Then, tissue was homogenized in 350 µL RLT buffer using an automatic bead mill 
(Tissue Lyser, Qiagen) and stainless steel beads (Ø 5 mm, Qiagen; 2 x 2 min, 18 s
-1
). After 
3 min of centrifugation (12,000 rpm; Biofuge Fresco, Heraeus, Hanau), supernatant was 
transferred to gDNA eliminator column and centrifuged again (15 s, 10,000 rpm). Supernatant 
was transferred into collection tube filled with 350 µL EtOH (70 %) and mixed to achieve 
RNA precipitation. The mixture was immediately transferred to RNeasy MinElute spin 
columns and centrifuged (15 s, 10,000 rpm). The eluate was discarded and the spin columns 
were washed with 700 µL RW1 buffer. Again, the eluate was discarded and the washing step 
was repeated with 500 µL RW1 buffer. After washing with 500 µL RPE buffer, columns were 
centrifuged (15 s, 10,000 rpm) and 500 µL EtOH (80 %) were added. Then, samples were 
centrifuged again (2 min, 10,000 rpm), the eluate was discarded and centrifugation was done 
again with open column lids to completely eliminate the EtOH. Finally RNA was eluted from 
the silica membrane of the spin columns using 14 µL nuclease free water. Samples were 
stored at -80 °C until further processing. 
 
Extraction of total RNA from primary hepatocytes or tissue samples (other than pituitary) 
Total RNA was obtained by using a phenol-chloroform extraction with Trizol Reagent 
according to the manufacturer´s protocol with little modifications. Frozen samples were 
homogenized in 700 µL Trizol Reagent using an automatic bead mill (Tissue Lyser, Qiagen) 
and stainless steel beads (Ø 5 mm, Qiagen). The Tissue Lyser was set on a shaking 
frequencies of 18 s
-1
 and homogenization was achieved by shaking two times for 1 min 30 s. 
Then, 600 µL of Trizol Reagent were added. Samples were centrifuged (Biofuge Fresco, 
Heraeus) for 10 min at 12,000 rpm (4 °C) and 1000 µL of the clear Trizol-phase were 
transferred into a new reaction tube. Depending on the color of the homogenate up to 300 µL 
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Trizol Reagent were added. Chloroform was added depending on the amount of Trizol 
Reagent (250 µL Chloroform upon 1300 µL Trizol Reagent). Samples were mixed vigorously 
(15 s) and incubated for 10 min at room temperature afterwards. Phases were separated by 
centrifugation (15 min, 12,000 rpm, room temperature) and 300 µl of the upper, aqueous 
phase were transferred into new reaction tubes and mixed with the equal volume of 
isopropanol. For RNA precipitation, samples were incubated at room temperature for 10 min 
and then another 60 min at -20 °C. After centrifugation for 12 min at 12,000 rpm (4 °C), the 
supernatant above the obtained RNA pellet was removed and the pellet was washed with 
300 µl ice-cold EtOH (70 %). Again, samples were centrifuged (6 min, 12,000 rpm, 4 °C), 
supernatant was removed and pellets were dried at room temperature. Dry pellets were cooled 
on ice and dissolved in nuclease free water depending on the size of the pellet (20-30 µL). 
Samples were then processed for RNA concentration measurements or stored at -80 °C until 
further analyses.  
2.4.6.2 Determination of total RNA concentration 
The amount and purity of extracted RNA was quantified by UV absorbance measurements 
using a Nanodrop ND-1000 spectrophotometer (NanoDrop Products, Thermo Fisher 
Scientific, Schwerte, Germany). The RNA concentration is based on the absorbance 
measurements at 260 nm (ng µL
-1
), while the purity of RNA is based on the ratios of 
absorbance measurements at 260 nm and 280 nm as well as at 230 nm and 280 nm. Samples 
of the same extraction series were diluted to the smallest possible RNA concentration, ideally 
set to 0.125 ng µL
-1
.   
2.4.6.3 Determination of RNA integrity 
The determination of the RNA quality based on the RNA integrity number (RIN) was 
performed for a randomly chosen subset of samples from each extraction using Agilent RNA 
6000 Nano kits analyzed in an Agilent 2100 Bioanalyzer (Agilent Technologies, Waldbronn, 
Germany). The RNA integrity is crucial for applications such as quantitative real time PCR 
(qPCR; Fleige and Pfaffl 2006). Size separation of the RNA molecules, especially ribosomal 
RNA 18S rRNA and 28S rRNA is necessary and automatically analyzed by chip-based micro 
capillary gel electrophoresis. An internal RNA marker and RNA ladder are sued as standards 
during the electrophoresis to allow molecule size estimations of RNA species. Prior to loading 
the chips, aliquots of RNA samples were denatured for 2 min at 70 °C (Thermocycler, 
Biometra). Chips were prepared according to the manufacturer´s protocol and 1 µL of each 
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sample (RNA concentration between 25-500 ng µL
-1
) was analyzed (eukaryotic total RNA 
setting). Corresponding RIN scores were calculated by the 2100 expert software (version 
B.02.05.SI360, Agilent Technologies). A RIN score of 10 indicates an intact RNA while a 
score of 1 characterizes a highly degraded RNA (Schroeder et al. 2006). The RIN scores of all 
samples analyzed were > 8 and therefore, RNA samples were of sufficient integrity.  
2.4.6.4 DNase treatment  
Prior to reverse transcription (RT), RNA from samples other than pituitary were treated with 
DNase I to remove contaminations of genomic DNA. A total of 1 µg RNA in 10 µL reaction 
volume was incubated for 15 min at room temperature with 1 µL reaction buffer and 1 µL 
DNase I. Immediately after incubation, DNase I was inactivated by adding 1 µL EDTA to the 
reaction mixture and incubation at 65 °C for 10 min was carried out in a thermal cycler 
(Biometra, Göttingen, Germany).  
2.4.6.5 Complementary DNA synthesis by reverse transcription  
All steps were performed on ice. Reverse transcription (RT) was carried out in a thermal 
cycler (Biometra, Göttingen, Germany). Due to a product replacement of the reverse 
transcriptase, different enzymes and protocols were applied for the in vitro and in vivo 
samples.  
 
Reverse transcription of total RNA from in vitro experiments 
Complementary DNA (cDNA) was reversely transcribed using Avian Myeloblastosis Virus 
Reverse Transcriptase (AMV-RT). For primer annealing, 17 µL of RNA (55 ng µL
-1
) was 
heated together with 3 µL poly(dt)-primer (1:40 diluted), having a final concentration of 
4 μM, at 70 °C for 3 min, and placed on ice afterwards. To perform reverse transcription 
10 μL premix containing 5 μL nuclease free water, 3 μL AMV-RT buffer, 1.5 μL dNTPs and 
0.5 μL AMV-RT were added to each sample. To test for the potential presence of genomic 
contaminations, negative control samples were prepared (0.5 µL nuclease free water instead 
of AMV-RT).  Incubation was carried out at 37 °C for 60 min and terminated by heating up to 
94 °C for 2 min. Samples were stored at −20 °C until used for qPCR. 
 
Reverse transcription of total RNA from in vivo experiments 
cDNA was reversely transcribed using Moloney Murine Leukemia Virus Reverse 
Transcriptase (MMLV-RT). For primer annealing, 6 µL of RNA (55 ng µL
-1
) was heated 
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together with 4 µL of premix 1 (3 µL nuclease free water + 1 µL poly(dt)-primer, 1:10 
diluted)  at 65 °C for 2 min, and placed on ice for 1 min afterwards. To perform reverse 
transcription 10 μL premix 2 containing 4.5 μL nuclease free water, 2 μL buffer, 2 µL DTT, 
1 μL dNTPs and 0.5 μL MMLV-RT were added to each sample. To test for the potential 
presence of genomic contaminations, negative control samples were prepared (0.5 µL 
nuclease free water instead of MMLV-RT).  Incubation was carried out at 37 °C for 60 min 
and terminated by heating up to 85 °C for 5 min. Samples were stored at -20 °C until used for 
qPCR. 
2.4.6.6 Gene expression analyses by quantitative real time PCR 
All qPCR reactions were run in a Stratagene MX3000 or 3005 real-time PCR cycler (Agilent, 
Böblingen, Germany) using Platinum Taq DNA polymerase. PCR reactions for all gene 
expression analyses were run with 2 µL cDNA in 20 µL reaction volume (0.4 µM primer, 1x 
PCR buffer, 2-3.0 mM MgCl2, 0.5 mM dNTPs, 0.1x SYBR-Green solution and 1 U Platinum 
Taq Polymerase) under the following thermal cycling conditions: initial denaturation at 95 °C 
for 7 min 40 s, followed by 40 cycles of denaturation at 95 °C for 17 s, primer annealing for 
25 s (see Table 7 for annealing temperatures) and extension at 72 °C for 25 s. Reference 
samples (calibrator) used to determine relative amounts of target transcript were produced by 
pooling cDNA samples from different treatments. PCR reactions were run in duplicates for all 
samples. qPCR data were analyzed using MxPro software (Stratagene) by means of the 
comparative CT method (ΔΔCT), including the corresponding amplification efficiencies 
(Pfaffl  2001). The housekeeping gene elongation factor 1α (EF1-a) was used as an internal 
standard by performing each PCR of any target gene and EF1-a from the same samples. 
Expressions of target genes were normalized to the corresponding level of EF1-a mRNA. In 
addition to samples without reverse transcriptase, no template control reactions (NTC, cDNA 
was replaced by nuclease free water) served as additional negative controls to check for the 
specificity of target cDNA amplification.  
2.4.6.7 Primer design and efficiency calculations 
Transcript-specific O. niloticus primers (Table 7) were either taken from literature sources 
(GST: Costa et al. 2012; MDRP: Ziková et al. 2010a, GH and IGF-I: Ziková et al. 2010b, LH 
and FSH: Mahdi El-Nadi 2011) or newly designed according to sequences published in the 
National Center for Biotechnology Information (NCBI), using Primer 3 
(http://primer3.wi.mit.edu/). All primers were synthesized by TibMol (Berlin, Germany) and 
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cycle numbers, annealing temperatures, MgCl2 and primer concentrations were optimized in a 
temperature gradient thermocycler (Eppendorf). PCR products were sized by gel 
electrophoresis (Agagel electrophoresis unit, Biometra) in a 2.0 % agarose gel in TAE-buffer 
(70 mV for 60 min). Therefore, 4 µL of PCR solution were mixed with 1 µL loading dye and 
transferred into the agarose gel. On each gel a 50 bp DNA-ladder (0.1 mg/mL) was included 
as a molecular size marker. Gels were analyzed using the gel documentation system GelDoc 
2000 (Biorad). Bands of PCR products of the expected size were purified from the agarose 
gels using QIAquick gel extraction kit (Qiagen). DNA concentrations of PCR samples were 
determined spectrophotometrically using the NanoDrop device and loading capacity of the 
columns was not exceeded. Five volumes of PB buffer were added to each PCR sample and 
the mixture was transferred to a QIAquick spin column, centrifuged for 30 s at 13,000 rpm 
and the flow-through was discarded. The columns were washed with 750 µL PE buffer, 
followed by centrifugation (30 s, 13,000 rpm). After drying the columns by centrifugation 
(1 min, 13,000 rpm), the DNA was eluted with 50 µL PCR water. Purified PCR products 
were stored at -20 °C. Sequencing of purified PCR products was performed by Sequence 
Laboratories (Göttingen, Germany). Specific amplification was confirmed by the data base 
homology search tool (BLAST). For each set of primers, the efficiency of the PCR reaction 
was determined by analyzing five-fold serial dilutions (spanning at least four orders of 
magnitude) of pooled cDNA  in duplicates. Standard curves were calculated by blotting the 
cycle threshold (CT) against the logarithm of the respective cDNA dilution (Pfaffl 2001). 
Resulting slopes from regression fit equations were used to determine the amplification 
efficiency according to: Efficiency = 10 
(-1/slope)
. Amplification efficiencies ranged between 85 
and 114 %.  
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Table 7. Primer used for gene expression analysis by real time PCR. bp: base pairs; Ta: annealing 
temperature. 
Target gene Forward (f) and reverse (r) primer  
5'-3' sequence 
Product 
length  
[bp] 
Ta 
[°C] 
NCBI 
accession 
number 
elongation factor 1α  
(EF-1a) 
f: gCTTCAACgCTCAggTCATC 
r: TgTgggCAgTgTggCAATC 
86 62 AB075952.1 
cytochrome P4501A 
monooxygenase (CYP1A) 
f:CTgACCTgTACAgCTTTCgC 
r: gCACATgAgTACTCTggggT 
153 62 AB048938.1 
glutathione- S-transferase 
(GST) 
f: AAATggATggCATgAAgCTC 
r: TCgTTCTTTgggATCCTTTg 
92 60 DQ397879 
multidrug resistance protein 
(MDRP) 
f: CAgATgggAATAAAgAAggCgA  
r: TgTCgATACTggggACgTgAT 
273 58 EU878755.1 
vitellogenin 
(VTG) 
f: CTTTCCATCCAgCCACCAAg 
r: CTgCAggAggTTgATgATgC 
160 60 FJ709597.1 
growth hormone 
(GH) 
f: CTgCTgATCAgggCCAATC 
r: TCgACATTTAgCTACCgTCAgg 
191 58 M97765.1 
M97766.1 
insulin-like growth factor I 
(IGF-I) 
f: AgTTTgTCTgTggAgAgCgAg 
r: gTgTgCCgCTgTgAACg 
188 58 EU272149.1 
follicle stimulating hormone 
(FSH) 
f: TgTCgCCCAAAgAACATCAgC 
r: TTCACCTCgTAggACCACTCTC 
158 62 AY294015.1 
luteinizing hormone 
(LH) 
f: ACCAAggACCCTgTCATC 
r: gCAgTggCAACTCAAAgC 
152 62 AY294016.1 
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2.4.7 Histology 
The third left gill arches of eight experimental fish from the long-term exposure experiments 
were evaluated histologically after 80 dph based on microscopic analyses of histopathological 
alterations. All chemicals and reagents used are listed in Table 8. 
 
Table 8. Chemical and reagents used for histological processing. 
Reagents Description Supplier 
ethanol (EtOH) ≥ 99.8 %, denatured; diluted with aqua dest.  Roth, Karlsruhe, Germany 
xylene 98 %; for histology Roth, Karlsruhe, Germany 
paraffin Paraplast PLUS, tissue embedding medium Roth, Karlsruhe, Germany 
eosin concentrate for microscopy; diluted to 0.1 % 
with aqua dest. 
Roth, Karlsruhe, Germany 
hematoxylin according to Harris Roth, Karlsruhe, Germany 
DePex mounting medium VWR 
 
2.4.7.1 Dehydration and paraffin embedding 
Gill tissue samples were dehydrated using an automatic tissue processor (Shandon 
Excelsior
TM
 ES, Thermo Scientific) according to the protocol given in Table 9. Samples were 
rinsed in a graded series of ethanol, xylene and paraffin.  
 
Table 9. Protocol for tissue dehydration and paraffin embedding. 
Step Solution Temperature Time (h:min) 
1. 75 % EtOH room temperature 1:00 
2. 90 % EtOH room temperature 1:00 
3. 95 % EtOH room temperature 1:00 
4. 95 % EtOH room temperature 1:00 
5. 100 % EtOH room temperature 1:00 
6. 100 % EtOH room temperature 1:00 
7. xylene room temperature 1:00 
8. xylene room temperature 1:00 
9. xylene room temperature 1:00 
10. paraffin 60 °C 1:20 
11. paraffin 60 °C 1:20 
12. paraffin 60 °C 1:20 
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Using an embedding centre consisting of a paraffin-dispenser (PA/5.9; C+E), a preheating 
unit (PA/W; C+E) and a paraffin stretching table (DDM-P064; MDS Group, Buseck, 
Germany) samples were placed into embedding moulds containing freshly melted paraffin. 
Gill arches were directed in a way that the primary filaments pointed to the right side.  
2.4.7.2 Sectioning and staining 
Samples were cut into 4 µm slices using a rotary microtome (Jung Supercut 2065; Leica, 
Wetzlar, Germany). Serial sections were transferred to a water bath (40 °C) for stretching out 
wrinkles, then mounted on microscope slides (Superfrost; Roth, Karlsruhe, Germany) and 
heat fixed at 60 °C overnight. Samples were stored at room temperature until staining. 
Staining was performed with hematoxylin and eosin according to Table 10. 
 
Table 10. Protocol for hematoxylin-eosin staining.  
Step Solution Time (min:s) 
1. xylene 5:00 
2. xylene 5:00 
3. 100 % EtOH 2:00 
4. 96 % EtOH 2:00 
5. 70 % EtOH 2:00 
6. 40 % EtOH 2:00 
7. aqua dest 2:00 
8. hematoxylin 2:00 
9. running tap water 10:00 
10. eosin (0.1 %) 1:00 
 
11. aqua dest. 0:15 
12. 80 % EtOH 2:00 
13. 96 % EtOH 2:00 
14. 100 % EtOH 2:00 
15. 100 % EtOH 2:00 
16. xylene 5:00 
17. xylene 5:00 
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2.4.7.3 Microscopic examination 
Histological evaluation was performed with gill samples from eight fish per treatment group. 
Samples were analyzed blindly at 1000 x magnification using a Olympus BX50 microscope 
equipped with a XC50 digital camera (Olympus, Hamburg, Germany). A total of 150 
secondary lamellae (SLs) per fish were analyzed. Therefore, five primary filaments per 
sample and 30 SLs per primary filament were chosen. Counting was started in the middle of 
the primary filaments. Dorsal and ventral secondary lamellae were included in same amounts. 
After a general survey of occurring pathological alterations according to Mallat (1985), six 
categories were defined for analysis: (a) not affected, (b) epithelial lifting, (c) hyperplasia 
(including lamellar fusion), (d) proliferation of mucous cells, (e) hypertrophy of chloride cells 
and (f) infiltration by leucocytes. Within these categories four degrees of severity were 
established depending on the area impaired or the amount of cells involved, respectively. 
Ranking was: without lesion = (-) , mild = (+), moderate = (++) and severe = (+++). 
2.4.8 Oxidative stress evaluation  
LPO is an often used indices for oxidative stress. The level of LPO was analyzed by the 
thiobarbituric acid reactive substances (TBARS) assay according to Lushchak et al. (2005) 
with some modifications. The decomposition of lipid hydroperoxides produces low molecular 
weight products, including malondialdehyde, which can be measured by the TBARS assay. 
Frozen tissue samples were homogenized (1:10 w/v) in 20 mM sodium phosphate (NaP) 
buffer, pH 7.0, containing 0.5 mM EDTA using an Ultra Turrax (Ika, Staufen, Germany). An 
aliquot of the homogenates (ideally 250 µL) was mixed with the same volume of sodium 
dodecyl sulfate (SDS; 7 %) and incubated for 5 min at room temperature. After incubation, 
samples were immersed in ice cold water and twice the volume of the initial aliquot of a 
solution containing 0.8 M HCl and 12.5 % trichloroacetic acid (TCA) was added. The same 
volume of thiobarbituric acid (TBA; 1 %, freshly prepared) was added. Samples were 
incubated for 45 min at 95 °C in a water bath. After quick cooling in ice cold water, the same 
butanol volume as the total mixture volume was added and samples were mixed vigorously. 
Samples were centrifuged for 10 min, 4 °C at 4,700 rpm and the butanol phase was removed 
and used for absorption measurements at 535 nm (Infinite 200, Tecan, Männedorf, 
Switzerland). Concentrations were calculated using a standard curve based on different 
concentrations of malondialdehyde (1,1,3,3-tetraethoxipropane) and are expressed in nmol of 
TBARS per gram wet weight of tissue.  
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2.4.9 Data analyses 
Data is presented as mean ± standard deviation of the mean (SD) or indicated otherwise. All 
statistical analyses were done using Graphpad Prism 4 software (GraphPad Software, Inc.). 
Data was tested for criteria of normality (Kolmogorov-Smirnov test) and homogeneity of 
variance (Barlett´s test) and transformed if necessary.  
 
Data obtained from the in vitro experiments was analyzed by paired t-test (parametric data) or 
Wilcoxon test for paired values (non-parametric data). Due to limited numbers of cell cultures 
(five fish with at least two technical replicates per fish and treatment) the significance level 
was set to p ≤ 0.06.  
 
Beside the statistical evaluation of the impaired secondary lamellae (SLs) based on the 
severity levels, data obtained from the in vivo experiments was analyzed by one-way analysis 
of variance (ANOVA) followed by Tukey´s HSD post hoc testing in case data met 
assumptions of parametric tests. In case data did not meet assumptions of normality and 
homogeneity of variance and transformation was not successful, Kruskal-Wallis one-way 
ANOVA was performed followed by Dunn´s multiple comparison test. Statistically 
significant differences between the impaired SLs were analyzed using two-way ANOVA with 
number of SLs and severity level as two factors, followed by Bonferroni post testing.  In all 
cases, p < 0.05 was considered to be statistically significant. 
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3 Results 
3.1 In vitro exposure to DCF and MTP 
During the experiment, O. niloticus primary hepatocytes could be kept alive. The integrity of 
the cells was verified using a microscope as described by Segner et al. (1993). According to a 
positive control, the expression level of a housekeeping gene (EF1-a) was nearly constant in 
all samples (data not shown).  
3.1.1 Cytochrome P4501A monooxygenase 
After 24 h exposure to DCF, biotransformation phase I enzyme CYP1A was statistically 
significant up-regulated in primary hepatocytes of O. niloticus for all three test concentrations 
compared to control treatment (Figure 12). The two lower test concentrations (4x10
-9
 M DCF 
and 4x10
-8
 M DCF) showed an increase of about 1.2-fold, while the highest test concentration 
(4x10
-7
 M DCF) led to an 1.6-fold increase. Exposure to MTP induced CYP1A gene 
expression of about 1.2 to 1.3-fold for all three concentrations tested. However, the change in 
CYP1A mRNA expression was only statistically significant at 4x10
-7
 M DCF compared to the 
control. 
 
Figure 12. Relative mRNA expression of cytochrome P4501A monooxygenase (CYP1A) in primary 
hepatocytes of Oreochromis niloticus after 24 h exposure to 0 (control), 4x10
-9
 M, 4x10
-8
 M and  
4x10
-7
 M diclofenac (light gray) and metoprolol (dark grey), respectively. Results (mean and SD) are 
expressed relative to control values and normalized to elongation factor 1-α (EF1-a) (n=5 with at least 
two technical replicates per fish and treatment). Asterisks indicate statistically significant differences 
to control (t-test for paired values, *p ≤ 0.06). 
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3.1.2 Glutathione-S-transferase 
Relative mRNA expression of GST increased dose-dependently for all DCF concentrations 
(Figure 13). While the two lower test concentrations (4x10
-9
 M and 4x10
-8
 M DCF) caused an 
increase of about 2-fold, the increase due to the highest test concentration (4x10
-9
 M DCF) 
was about 4.3-fold.  Exposure to MTP changed GST expression levels statistically significant 
only at the lowest concentration of 4x10
-9
 M MTP (1.8-fold) compared to control treatment. 
The two higher concentrations increased GST gene expression between 2.2 and 1.6-fold.  
 
 
Figure 13. Relative mRNA expression of glutathione-S-transferase (GST) in primary hepatocytes of 
Oreochromis niloticus after 24 h exposure to 0 (control), 4x10
-9
 M, 4x10
-8
 M and 4x10
-7
 M diclofenac 
(light gray) and metoprolol (dark grey), respectively. Results (mean and SD) are expressed relative to 
control values and normalized to elongation factor 1-α (EF1-a) (n=5 with at least two technical 
replicates per fish and treatment). Asterisks indicate statistically significant differences to control 
(Wilcoxon test for paired values, *p ≤ 0.06). 
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3.1.3 Multidrug resistance protein 
Relative mRNA expression levels of MDRP were statistically significant different compared 
to the control after 24 h exposure to 4x10
-9
 M DCF (Figure 14). Expression levels tended to 
increase with elevating concentrations (between 1.9 to 3.0-fold). MTP did not significantly 
change MDRP mRNA levels at any concentration tested, but mean values were between 1.8 
and 2.7-fold higher compared to the control treatment. 
 
 
Figure 14. Relative mRNA expression of multidrug resistance protein (MDRP) in primary hepatocytes 
of Oreochromis niloticus after 24 h exposure to 0 (control), 4x10
-9
 M, 4x10
-8
 M and 4x10
-7
 M 
diclofenac (light gray) and metoprolol (dark grey), respectively. Results (mean and SD) are expressed 
relative to control values and normalized to elongation factor 1-α (EF1-a) (n=5 with at least two 
technical replicates per fish and treatment). Asterisks indicate statistically significant differences to 
control (Wilcoxon test for paired values,*p ≤ 0.06). 
 
3.1.4 Vitellogenin 
With increasing concentrations of DCF, relative mRNA expression of VTG in O. niloticus 
primary hepatocytes increased (1.3 to 3.0-fold; Figure 15). In comparison to the control 
group, this increase was statistically significant for 4x10
-9
 M and 4x10
-7
 M DCF. Exposure to 
MTP increased VTG mRNA expression statistically significant only at the second highest test 
concentration (4x10
-8
 M MTP; 1.6-fold) compared to the control group. EE2 induced VTG 
mRNA expression statistically significant compared to the control group (2.0-fold).  
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Figure 15. Relative mRNA expression of vitellogenin (VTG) in primary hepatocytes of Oreochromis 
niloticus after 24 h exposure to 0 (control), 4x10
-9
 M, 4x10
-8
 M and 4x10
-7
 M diclofenac (light gray) 
and  metoprolol (dark grey), respectively. EE2 (17 α-Ethinylestradiol; 10
-6
 M) was used as positive 
control. Results (mean and SD) are expressed relative to mean control and normalized to elongation 
factor 1-α (EF1-a) (n=5 with at least two technical replicates per fish and treatment). Asterisks indicate 
statistically significant differences to control (Wilcoxon test for paired values, *p ≤ 0.06). 
 
3.2 In vivo exposure 
Water parameters could be kept nearly constant throughout the in vivo experiments        
(Table 11), confirming optimal experimental conditions. In the following, nominal 
concentrations are used instead of the effective ones to simplify the denotation of the different 
treatment groups. 
 
Table 11. Water parameters throughout the long-term exposure experiments. 
Substance Water temperature [°C] pH Oxygen [mg/L] 
diclofenac 27.4 ± 0.4 7.62 ± 0.30 7.11 ± 0.55 
metoprolol 27.4 ± 0.4 7.66 ± 0.25 7.16 ± 0.42 
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3.2.1 Diclofenac 
3.2.1.1 DCF analytics 
DCF was not detectable in the control treatment. The effective DCF concentrations in the test 
water samples of the treatment concentrations were in the range of 99-112 % of the nominal 
values during the exposure experiment (Table 12). The Organization for Economic Co-
operation and Development (OECD) test guidelines require 80 to 120 % of nominal and 
therefore, measured values are considered to be reliable.  
 
Table 12. Diclofenac exposure experiment. Nominal concentrations and mean ± standard deviation 
(SD) of the actual exposure concentrations [µg L
-1
] during the entire experiment, including percentage 
of the nominal concentrations. n.d.: not detectable. 
Treatment 
[M] 
Nominal concentration 
[µg L
-1
] 
Mean measured concentration  
± SD [µg L
-1
] 
% of nominal 
concentration ± SD 
control 0 n.d. n.d 
4x10
-10
 0.13 0.15 ± 0.03 112 ± 20 
4x10
-9
 1.27 1.37 ± 0.17 107 ± 14 
4x10
-8
 12.72 12.59 ± 2.76   97 ± 23 
4x10
-7
 127.24 137.71 ± 30.59 111 ± 25 
 
3.2.1.2 Hatching 
Hatching of O. niloticus larvae was completed after four days of exposure. The mean hatching 
rate of the control group was 99 ± 2 % (mean ± SD). Hatching success was not significantly 
affected by DCF exposure. For all treatment groups mean hatching success was almost equal 
to the control group, ranging from 96 ± 5 % to 99 ± 3 % (mean ± SD) (Figure 16).  
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Figure 16. Hatching rates [%] of  Oreochromis niloticus exposed to diclofenac (mean and SD). Data 
was analyzed using Kruskal-Wallis test revealing no statistical significant differences between 
treatment groups. 
 
3.2.1.3 Survival 
Survival of O. niloticus was not affected by DCF exposure (Figure 17). Mean survival of the 
control fish throughout the experiment was 69 ± 9 % (mean ± SD), while the treatment groups 
ranged between 65 ± 15 % to 80 ± 12 % (mean ± SD) and did not differ significantly from the 
control. Almost no fish died until 8 dph but for all treatment groups, mortality was found to 
be highest between 9 to 30 dph of exposure (Figure 18).   
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Figure 17. Survival [%] of Oreochromis niloticus exposed to diclofenac for 80 days post-hatch (mean 
and SD). Data was analyzed using Kruskal-Wallis test revealing no statistical significant differences 
between treatment groups. 
 
 
Figure 18. Cumulative mortality [%] of Oreochromis niloticus exposed to diclofenac for various time 
phases until 80 days post-hatch (dph). 
 
3.2.1.4 Growth 
After 8 and 30 dph of DCF exposure, fish wet weight was not impaired by any DCF treatment 
concentration (Figure 19 A/B). After 80 dph wet weight of exposed fish was slightly reduced 
and ranged between 92 - 97 % of the control group (Figure 19 C). Exposure to 4x10
-8
 M DCF 
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reduced wet weight significantly compared to the control group. The same pattern was found 
for fish length (Figure 20).  
 
 
Figure 19. Wet weight [g] of Oreochromis niloticus after (A) 8, (B) 30 and (C) 80 days post-hatch of 
diclofenac exposure, respectively. The arithmetic means and SD were calculated from the mean values 
of the four tank replicates per treatment (n=11 or 12 at all sampling points). Asterisks indicate 
statistically significant differences to control (Dunn´s Multiple Comparison test, *p < 0.05). 
 
 
Figure 20. Length [mm] of Oreochromis niloticus after (A) 8, (B) 30 and (C) 80 days post-hatch of 
diclofenac exposure, respectively. The arithmetic means and SD were calculated from the mean values 
of the four tank replicates per treatment (n=11 or 12 at all sampling points). Asterisks indicate 
statistically significant differences to control (Tukey´s Multiple Comparison test, *p < 0.05). 
 
Based on the individual length and wet weight, the condition index (CI) was calculated  
(Table 13). After 8 dph, CI did not differ statistically significant, although the CI of the 
control group was slightly higher than in the DCF exposure groups. Only after 30 dph,    
4x10
-8
 M DCF reduced CI statistically significant compared to the control group. Again, no 
significant changes were found after 80 dph.   
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Table 13. Condition index [g/cm³] of Oreochromis niloticus exposed to diclofenac for 8, 30 and 80 
days post-hatch (dph), respectively. Means and standard deviation (SD) are presented (n=11 or 12 at 
all sampling points). Asterisks indicate statistically significant differences to control (Dunn´s Multiple 
Comparison test, *p < 0.05). 
 
 
Effects of DCF exposure on the growth axis were partly analyzed, namely by gene expression 
analysis of growth hormone (GH, Figure 21 A) and insulin-like growth factor I (IGF-I,  
Figure 21 B). No statistically significant changes in gene expression were found, but GH 
showed the tendency to increase while there was a constant decrease in IGF-I mRNA 
expression with increasing DCF concentrations. Exposure to 4x10
-7
 M DCF caused a lower 
expression level of IGF-I of about 50 % compared to the control group.  
 
 
Figure 21. Relative mRNA expression of (A) growth hormone (GH) and (B) insulin-like growth factor 
I (IGF-I) in pituitary and liver, respectively, of Oreochromis niloticus after 80 days post-hatch of 
diclofenac exposure. Results (mean and SD) are expressed relative to control values and normalized to 
elongation factor 1-α (EF1-a) (n=8). Data was analyzed using Kruskal-Wallis test revealing no 
statistically significant differences between treatment groups. 
 
 
 8 dph 30 dph 80 dph 
control 1.31 ± 0.37 1.53 ± 0.25 1.40 ± 0.05 
4x10
-10
 M 1.08 ± 0.23 1.56 ± 0.08 1.38 ± 0.06 
4x10
-9 
 M 1.07 ± 0.18 1.55 ± 0.07 1.38 ± 0.06 
4x10
-8
  M 1.15 ± 0.22 1.47 ± 0.06 * 1.56 ± 0.71 
4x10
-7
  M 1.19 ± 0.31 1.50 ± 0.09 1.33 ± 0.07 
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3.2.1.5 Hepatosomatic index 
The hepatosomatic index (HSI) increased statistically significant after 30 dph of DCF 
exposure (Table 14) with the highest value (3.33 ± 0.30 %) at the highest DCF treatment 
concentration. Compared to the control group, the increase was statistically significant for 
4x10
-9
 M as well as 4x10
-7
 M DCF. Furthermore, 4x10
-9 
M had a greater HSI than 4x10
-10
 M. 
After 80 dph, the HSI was in general much smaller than after 30 dph, but no statistical 
differences between treatment groups occurred.  
 
Table 14. Hepatosomatic index [%] of Oreochromis niloticus exposed to diclofenac for 30 and 80 days 
post-hatch (dph). Means and standard deviation (SD) are presented (n=11 or 12). Letters indicate 
statistically significant differences between treatments (Dunn´s Multiple Comparison test, p < 0.05). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 30 dph 80 dph 
control 2.68 ± 0.79 a  0.60 ±0.07   
4x10
-10
 M 2.56 ± 0.43 ac 0.70 ± 0.14  
4x10
-9 
 M 3.32 ± 0.11 b 0.70 ± 0.11  
4x10
-8
  M 3.05 ± 0.44 abc 0.64 ± 0.05  
4x10
-7
  M 3.33 ± 0.30 bc 0.59 ± 0.10  
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3.2.1.6 Histology 
Using light microscopic examinations of gills of O. niloticus after 80 dph of exposure to DCF, 
various histopathological alterations could be observed. Overall, the DCF treatment groups 
showed statistically significant more SLs with histopathological alterations compared to the 
control group (except for 4x10
-7
 M DCF, Figure 22). All treatment groups showed around 
70 % of SLs with alterations while in the control group less than 40 % were affected. In total, 
epithelial lifting and the proliferation of epithelial cells (hyperplasia) occurred most often, 
followed by hypertrophy of chloride cells (Figure 23). Within all categories, mild alterations 
were observed most often, but epithelial lifting also occurred notably in a moderate and 
severe manner. A statistically significant increase in certain alterations due to DCF exposure, 
however, was only determined for mild alterations of epithelial lifting (Figure 23 A and 
Figure 24 B), hypertrophy (Figure 23 B and Figure 24 D) and hyperplasia (Figure 23 C and 
Figure 24 C).  
 
 
Figure 22. Total number of secondary lamellae (and SD) with histopathological alterations in gills of 
Oreochromis niloticus after 80 days post-hatch of diclofenac exposure (n=8). Asterisks indicate 
statistically significant differences to control (Tukey´s Multiple Comparison test, *p < 0.05). 
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Figure 23. Mean number of secondary lamellae (out of 150) and SD in gills of Oreochromis niloticus 
with the following findings after 80 days post-hatch of diclofenac exposure: (A) epithelial lifting, (B) 
hypertrophy of chloride cells, (C) hyperplasia, (D) proliferation of mucous/chloride cells, (E) 
infiltration by leucocytes. Alterations are categorized: (+) mild, (++) moderate, (+++) severe. Note 
varying scales. Asterisks indicate statistically significant differences to control within one severity 
level of lamellar damage (Bonferroni post test, *p < 0.05, **p < 0.01, ***p < 0.001). 
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Figure 24. Gill histology of Oreochromis niloticus after 80 days post-hatch under experimental 
conditions. (A) control, (B-D) exposure to 4x10
-7
 M diclofenac. Histopathological alterations: (B) 
epithelial lifting (dotted black arrow) and hypertrophy of chloride cells (solid black arrows), (C) 
hyperplasia, (D) hypertrophy of chloride cells (solid black arrows), infiltration by leucocytes 
(eosinophile granulocytes, red arrows, occasionally observed). Original magnification 400 x, scale bar 
corresponds to 50 µm, sections of 4 µm thickness and stained by hematoxylin and eosin method. 
 
3.2.1.7 Gene expression of pituitary gonadotropins and hepatic vitellogenin 
Gene expression patterns of both pituitary gonadotropins, namely luteinizing hormone (LH) 
and follicle stimulating hormone (FSH) were analyzed to gain information about the influence 
of DCF exposure on the hypothalamus-pituitary-gonad axis (HPG axis, Figure 25). LH 
expression was statistically significant reduced with increasing DCF concentrations 
comparing the control group with 4x10
-9
 M and 4x10
-7
 M DCF (Figure 25 A). DCF exposure 
had no statistically significant effect on the expression levels of FSH (Figure 25 B). 
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Figure 25. Relative mRNA expression of (A) luteinizing hormone (LH) and (B) follicle stimulating 
hormone (FSH) in the pituitary of Oreochromis niloticus after 80 days post-hatch of diclofenac 
exposure. Results (mean and SD) are expressed relative to control values and normalized to elongation 
factor 1-α (EF1-a) (n=6 to 8). Asterisks indicate statistically significant differences to control (Dunn´s 
Multiple Comparison test, *p < 0.05). 
 
Relative mRNA expression of vitellogenin (VTG, Figure 26) increased in a non-monotonic 
dose response manner, with a distinct peak at 4x10
-9
 M DCF, leading to an inverted U-shape 
expression pattern. Overall, the increase was 1.5 to 3.8-fold. In comparison to the control 
group, this increase was statistically significant for 4x10
-9
 M DCF. 
 
 
Figure 26. Relative mRNA expression of vitellogenin (VTG) in the liver of Oreochromis niloticus 
after 80 days post-hatch of diclofenac exposure. Results (mean and SD) are expressed relative to 
control values and normalized to elongation factor 1-α (EF1-a) (n=6). Asterisks indicate statistically 
significant differences to control (Tukey´s Multiple Comparison test, *p < 0.05). 
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3.2.1.8 Biotransformation 
Relative mRNA expression of key enzymes of the three phases of the biotransformation 
pathways was analyzed at all sampling points, using whole larvae after 8 dph and liver 
samples after 30 and 80 dph, respectively. After 8 and 30 dph of DCF exposure no differences 
in expression patterns for all three enzymes were found (data not shown). After 80 dph 
(Figure 27), an induction was found with increasing DCF concentrations (with exception for 
4x10
-7
 M DCF). The increase was statistically significant for GST at 4x10
-9
 M and           
4x10
-8
 M DCF and for MDRP at 4x10
-8
 M DCF compared to the control group. MDRP 
induction was the highest with about 5-fold compared to the control group.  
 
 
 
Figure 27. Relative mRNA expression of (A) cytochrome P4501A monooxygenase (CYP1A), (B) 
glutathione-S-transferase (GST) and (C) multidrug resistance protein (MDRP) in the liver of 
Oreochromis niloticus after 80 dph of diclofenac exposure. Results (mean and SD) are expressed 
relative to control values and normalized to elongation factor 1-α (EF1-a) (n=7). Asterisks indicate 
statistically significant differences to control (Dunn´s Multiple Comparison test *p<0.05, **p<0.01). 
 
Additionally, CYP1A and GST gene expression was analyzed in gills of O. niloticus after 
80 dph of DCF exposure (Figure 28). CYP1A gene expression was not statistically significant 
influenced by DCF exposure but showed the tendency to decrease with increasing DCF 
concentrations (Figure 28 A). GST gene expression was induced for the two lower DCF 
treatment groups and clearly reduced for the two higher DCF concentrations (Figure 28 B). 
The induction was statistically significant comparing the control group and 4x10
-9
 M DCF.  
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Figure 28. Relative mRNA expression of (A) cytochrome P4501A monooxygenase (CYP1A) and (B) 
glutathione-S-transferase (GST) in the gills of Oreochromis niloticus after 80 dph of diclofenac 
exposure. Results (mean and SD) are expressed relative to control values and normalized to elongation 
factor 1-α (EF1-a) (n=5 or 6). Letters indicate statistically significant differences between treatments 
(Tukey´s Multiple Comparison test, p < 0.05). 
 
3.2.1.9 Oxidative stress  
Overall, levels of TBARS in various tissues of O. niloticus were quite different, ranging from 
around 0.5 nmol/g wet weight in muscle tissue up to 4.5 nmol/g wet weight in brain samples 
(Figure 29 A-C). Only TBARS levels found in brain tissue (Figure 29 A) showed the 
tendency to increase with increasing DCF concentrations and TBARS level of 4x10
-8 
M DCF 
was statistically significant higher than in the control group. No effect on TBARS levels in 
gills and muscles was found.  
 
 
Figure 29. Levels of thiobarbituric acid reactive substances (TBARS) in (A) brain, (B) gills and (C) 
muscles of Oreochromis niloticus after 80 days post-hatch of diclofenac exposure (mean and SD) (n=5 
or 6). Letters indicate statistically significant differences between treatment groups (Tukey´s Multiple 
Comparison test, p < 0.05). 
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3.2.2 Metoprolol 
3.2.2.1 MTP analytics 
MTP was not detectable in the control treatment. The effective MTP concentrations in the test 
water samples of the treatment concentrations were in the range of 100-112 % of the nominal 
values during the exposure experiment (Table 15). Again, according to OECD test guidelines 
80 to 120 % of nominal are required and therefore, measured values are considered to be 
reliable.  
 
Table 15. Metoprolol exposure experiment. Nominal concentrations and mean ± standard deviation 
(SD) of the actual exposure concentrations [µg L
-1
] during the experiment, including percentage of the 
nominal concentrations. n.d.: not detectable. 
Treatment 
[M] 
Nominal concentration 
[µg L
-1
] 
Mean measured concentration  
± SD  [µg L
-1
] 
% of nominal 
concentration ± SD 
control 0 n.d. n.d. 
4x10
-10
 0.11 0.12 ± 0.03 110 ± 23 
4x10
-9
 1.07 1.20 ± 0.24 116 ± 22 
4x10
-8
 10.69 11.61 ± 3.17 109 ± 30 
4x10
-7
 106.94 116.86 ± 40.00 115 ± 37 
 
3.2.2.2 Hatching 
Hatching of O. niloticus larvae was completed after four days of exposure. The mean hatching 
rate of the control group was 99 ± 3 % (mean ± SD). Hatching success was not statistically 
significant affected by MTP exposure. For all treatment groups mean hatching success was 
almost equal to the control group, ranging from 97 ± 6 % to 99 ± 2 % (mean ± SD)       
(Figure 30).  
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Figure 30. Hatching rates [%] of  Oreochromis niloticus exposed to metoprolol (mean and SD). Data 
was analyzed using Kruskal-Wallis test revealing no statistical significant differences between 
treatment groups. 
 
3.2.2.3 Survival 
Survival of O. niloticus was slightly reduced when exposed to MTP but not significantly 
affected (Figure 31). Mean survival of the control fish throughout the experiment was 
72 ± 8 % (mean ± SD), while the treatment groups ranged between 57 ± 18 % to 70 ± 8 % 
(mean ± SD). Almost no fish died until 8 dph and mortality was almost equal after 30 and 
80 dph of MTP exposure (Figure 32).  
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Figure 31. Survival [%] of Oreochromis niloticus exposed to metoprolol for 80 days post-
hatch (mean and SD). Data was analyzed using Kruskal-Wallis test revealing no statistical 
significant differences between treatment groups. 
 
 
Figure 32. Cumulative mortality [%] of Oreochromis niloticus exposed to metoprolol for various time 
phases until 80 days post-hatch (dph). 
 
3.2.2.4 Growth 
After 8 dph of MTP exposure, fish wet weight was not impaired (Figure 33 A). After 30 and 
80 dph, wet weight was reduced almost dose-dependently (Figure 33 B/C). A MTP 
concentration of 4x10
-10
 M caused a reduction in wet weight of only 4 % compared to the 
control group but the other treatment groups ranged between 87-67 % of the control group. 
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After 80 dph, wet weight was slightly greater when fish were exposed to 4x10
-10
 M MTP 
(108 % of control group) or equal when exposed to 4x10
-9
 M MTP. At higher MTP 
concentrations wet weight ranged between 84 - 82 % of the control group.  
 
 
Figure 33. Wet weight [g] of Oreochromis niloticus after (A) 8, (B) 30 and (C) 80 days post-hatch of 
metoprolol exposure, respectively. The arithmetic means and SD were calculated from the mean 
values of the four tank replicates per treatment (n=11 or 12 at all sampling points). Letters indicate 
statistically significant differences between treatments (Tukey´s Multiple Comparison test, p < 0.05). 
 
At all sampling points, fish length was slightly affected by MTP exposure (Figure 34). After 
8 dph (Figure 34 A), length of exposed fish ranged between 103-98 % of the control group. A 
statistically significant difference only occurred between 4x10
-10
 M and 4x10
-7
 M MTP.  After 
30 dph (Figure 34 B), length was reduced dose-dependently, ranging from 98-88 % of the 
control group. Differences were statistically significant comparing the control group and the 
two lowest MTP treatment groups with the highest MTP concentration. After 80 dph    
(Figure 34 C), 4x10
-8
 M MTP caused a statistically significant reduction of fish length 
compared to the control. Overall, length ranged between 103 - 94 % of the control group.  
 
 
Figure 34. Length [mm] of Oreochromis niloticus after (A) 8, (B) 30 and (C) 80 days post-hatch of 
metoprolol exposure, respectively. The arithmetic means and SD were calculated from the mean 
values of the four tank replicates per treatment (n=11 or 12 at all sampling points). Letters indicate 
statistically significant differences between treatments (Tukey´s Multiple Comparison test, p < 0.05). 
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Based on the individual length and wet weight, the condition index (CI) was calculated  
(Table 16). Differences between treatment groups were found after 80 dph of MTP exposure. 
Fish exposed to 4x10
-10
 M MTP had the highest CI, statistically significant greater than fish 
exposed to 4x10
-7
 M MTP.   
  
Table 16. Condition index [g/cm³] of Oreochromis niloticus exposed to metoprolol for 8, 30 and 80 
days post-hatch (dph), respectively. Means and standard deviation (SD) are presented (n=11 or 12 at 
all sampling points). Letters indicate statistically significant differences between treatments (Dunn´s 
Multiple Comparison test). 
 
 
Effects of MTP exposure on the growth axis were partly analyzed, namely by gene expression 
analysis of growth hormone (GH, Figure 35 A) and insulin-like growth factor I (IGF-I,  
Figure 35 B). No statistically significant changes in gene expression were found. Besides 
exposure to 4x10
-10
 M MTP, GH mRNA expression had a little tendency to decrease with 
increasing MTP concentrations. IGF-I gene expression showed no trend at all.   
 
 
 
 8 dph 30 dph 80 dph 
control 1.34 ± 0.34 1.54 ± 0.06 1.38 ± 0.40 ab 
4x10
-10
 M 1.31 ± 0.18 1.6 ± 0.07 1.7 ± 0.31   a 
4x10
-9 
 M 1.44 ± 0.12 1.55 ± 0.10 1.54 ± 0.28 ab 
4x10
-8
  M 1.44 ± 0.3 1.62 ± 0.09 1.49 ± 0.33 ab 
4x10
-7
  M 1.33 ± 0.22 1.53 ± 0.13 1.23 ± 0.34 b 
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Figure 35. Relative mRNA expression of (A) growth hormone (GH) and (B) insulin-like growth factor 
I (IGF-I) in pituitary and liver, respectively, of Oreochromis niloticus after 80 days post-hatch of 
metoprolol exposure. Results (mean and SD) are expressed relative to control values and normalized 
to elongation factor 1-α (EF1-a) (n=7 or 8). Data was analyzed using one way ANOVA revealing no 
statistically significant differences between treatment groups. 
 
3.2.2.5 Hepatosomatic index 
The HSI did not differ statistically significant due to MTP exposure, neither 30 nor 80 dph 
(Table 17). After 80 dph, the HSI tended to increase with higher MTP concentrations. The 
HSI due to 4x10
-7
 M MTP was about one third higher compared to the control group. 
 
Table 17. Hepatosomatic index [%] of Oreochromis niloticus exposed to metoprolol for 30 and 80 
days post-hatch (dph). Means and standard deviation (SD) are presented (n=10 to 12). Data was 
analyzed using one way ANOVA revealing no statistical significant differences between treatment 
groups. 
 
 
 
 30 dph 80 dph 
control 2.98 ± 0.21 0.66 ±0.09   
4x10
-10
 M 3.41 ± 0.35 0.75 ± 0.04 
4x10
-9 
 M 3.20 ± 0.29 0.79 ± 0.13  
4x10
-8
  M 2.98 ± 0.58 0.72 ± 0.13  
4x10
-7
  M 2.81 ± 0.55 0.89 ± 0.05  
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3.2.2.6 Histology 
Using light microscopic examinations of gills of O. niloticus after 80 dph of exposure to 
MTP, only few histopathological alterations could be observed. Overall, MTP exposure had 
no effect on the total number of SLs with alterations (Figure 36). In the control group 54 % of 
SLs were affected. In the MTP treatment groups between 40 - 56 % of SLs were affected. In 
total, hyperplasia and hypertrophy of chloride cells occurred most often. Moderate alterations 
were only found occasionally but severe alterations were almost not found at all. Compared to 
the control group, epithelial lifting occurred significantly less after 4x10
-9
 M MTP exposure 
(Figure 37 A and Figure 38 D) but no difference between the other treatment groups were 
found. Hypertrophy was found more often in the MTP treatment groups, but differences were 
not statistically significant (Figure 37 B). Hyperplasia of epithelial cells tended to be most 
abundant in the control group as well as 4x10
-10
 M MTP (Figure 37 C and Figure 38 B), but 
again no statistically significant effect was found. In contrast, proliferation of cells occurred 
dose-dependently (Figure 37 D) with statistically significant differences to the control group 
for the three highest MTP concentrations. Leucocytes were found most often in the          
4x10
-7
 M MTP treatment, being significant compared to the control group (Figure 37 E and 
Figure 38 C).  
 
 
Figure 36. Total number of secondary lamellae (and SD) with histopathological alterations in gills of 
Oreochromis niloticus after 80 days post-hatch of metoprolol exposure (n=8). Data was analyzed 
using one way ANOVA revealing no statistical significant differences between treatment groups. 
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Figure 37. Mean number of secondary lamellae (out of 150) and SD in gills of Oreochromis niloticus 
with the following findings after 80 days post-hatch of metoprolol exposure: (A) epithelial lifting, (B) 
hypertrophy of chloride cells, (C) hyperplasia, (D) proliferation of mucous/chloride cells, (E) 
infiltration by leucocytes. Alterations are categorized: (+) mild, (++) moderate, (+++) severe. Note 
varying scales. Asterisks indicate statistically significant differences to control within one severity 
level of lamellar damage (Bonferroni post test *p < 0.05, **p < 0.01). 
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Figure 38. Gill histology of Oreochromis niloticus after 80 days post-hatch under experimental 
conditions. (A) control, (B-D) exposure to 4x10
-7
 M metoprolol. Histopathological alterations: (B) 
hyperplasia, (C) infiltrations by leucocytes (red arrows) and hypertrophy of chloride/mucus cells (solid 
black arrows) and (D) epithelial lifting (dotted black arrows). Original magnification 400 x, scale bar 
corresponds to 50 µm, sections of 4 µm thickness and stained by hematoxylin and eosin method. 
 
3.2.2.7 Gene expression of pituitary gonadotropins and hepatic vitellogenin 
Gene expression patterns of both pituitary gonadotropins, luteinizing hormone (LH) and 
follicle stimulating hormone (FSH) were analyzed to gain information about the influence of 
MTP exposure on the hypothalamus-pituitary-gonad axis (HPG axis, Figure 39). Expression 
patterns were similar for both hormones. Exposure to 4x10
-10
 M MTP caused the highest 
mRNA expression (LH: 1.9-fold, FSH: 1.5-fold compared to control). All other MTP 
treatment concentrations possessed a lower gene expression compared to the control as well 
as the lowest MTP treatment group. Statistically significant differences were not found 
compared to the control group but comparing 4x10
-10
 M MTP to 4x10
-8
 M and 4x10
-7
 M 
considering LH (Figure 39 A) and comparing 4x10
-10
 M MTP to 4x10
-9
 M and 4x10
-7
 M MTP 
considering FSH (Figure 39 B).  
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Figure 39. Relative mRNA expression of (A) luteinizing hormone (LH) and (B) follicle stimulating 
hormone (FSH) in the pituitary of Oreochromis niloticus after 80 days post-hatch of metoprolol 
exposure. Results (mean and SD) are expressed relative to control values and normalized to elongation 
factor 1-α (EF1-a) (n=6 to 8). Letters indicate statistically significant differences between treatments 
(Tukey´s Multiple Comparison, p < 0.05). 
 
Relative mRNA expression of VTG (Figure 40) increased only statistically significant due to 
exposure to 4x10
-7
 M MTP. The induction was about 2.9-fold. The lower MTP concentrations 
had almost no effect on VTG gene expression. 4x10
-10
 M MTP caused no change in 
expression pattern, while 4x10
-9
 M and 4x10
-8
 M MTP induced the expression level 1.4- and 
1.3-fold, respectively.  
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Figure 40. Relative mRNA expression of vitellogenin (VTG) in the liver of Oreochromis niloticus 
after 80 days post-hatch of metoprolol exposure. Results (mean and SD) are expressed relative to 
control values and normalized to elongation factor 1-α (EF1-a) (n=7). Asterisks indicate statistically 
significant differences to control (Tukey´s Multiple Comparison test *p<0.05). 
 
3.2.2.8 Biotransformation 
Relative mRNA expression of three key enzymes of the biotransformation pathways was 
analyzed at all sampling points, using whole larvae after 8 dph and liver samples after 30 and 
80 dph, respectively. Gene expression patterns were not significantly changed due to MTP 
exposure at any sampling point. Exemplary, gene expression levels after 80 dph of MTP 
exposure are shown (Figure 41). MTP increased CYP1A gene expression with the highest 
induction due to 4x10
-7
 M MTP (3.6-fold, Figure 41 A). Relative mRNA of GST was almost 
not altered due to MTP exposure at all (Figure 41 B), while MDRP gene expression had 
higher values due to MTP exposure, ranging from almost 2-fold to 2.7-fold with increasing 
MTP concentrations (Figure 41 C).  
 
  Results 
65 
 
 
Figure 41. Relative mRNA expression of (A) cytochrome P4501A monooxygenase (CYP1A), (B) 
glutathione-S-transferase (GST) and (C) multidrug resistance protein (MDRP) in the liver of 
Oreochromis niloticus after 80 dph of metoprolol exposure. Results (mean and SD) are expressed 
relative to control values and normalized to elongation factor 1-α (EF1-a) (n=6 or 7). Data was 
analyzed using Kruskal-Wallis test revealing no statistically significant differences between treatment 
groups. 
 
Additionally, CYP1A and GST gene expression was analyzed in gills of O. niloticus after 
80 dph of MTP exposure (Figure 42). Except for 4x10
-9
 M MTP, CYP1A gene expression 
tended to increase with increasing MTP concentrations, although being statistically not 
significant (Figure 42 A). The decrease at 4x10
-9
 M MTP was statistically significant 
compared to 4x10
-10
 M MTP. No effect of MTP exposure on GST gene expression was found 
(Figure 42 B). 
 
 
Figure 42. Relative mRNA expression of (A) cytochrome P4501A monooxygenase (CYP1A) and (B) 
glutathione-S-transferase (GST) in the gills of Oreochromis niloticus after 80 dph of exposure to 
metoprolol. Results (mean and SD) are expressed relative to control values and normalized to 
elongation factor 1-α (EF1-a) (n=5 or 6). Letters indicate statistically significant differences between 
treatments (Dunn´s Multiple Comparison test, p<0.05). 
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3.2.2.9 Oxidative stress  
In brain tissue of O. niloticus, TBARS levels were statistically significant higher after 
exposure to 4x10
-10 
M and 4x10
-8 
M MTP compared to the control group (Figure 43 A). The 
two other MTP treatment concentrations had no effect. The same pattern was found in muscle 
tissue (Figure 43 C). In gills, no effect of MTP exposure on TBARS levels occurred but  
4x10
-7 
M MTP caused a non-significant increase of about 2-fold compared to all other groups 
(Figure 43 B).     
 
 
Figure 43. Levels of thiobarbituric acid reactive substances (TBARS) in (A) brain, (B) gills and (C) 
muscles of Oreochromis niloticus after 80 days post-hatch of metoprolol exposure (mean and SD) 
(n=6). Letters indicate statistically significant differences between treatment groups (Tukey´s Multiple 
Comparison test). 
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4 Discussion 
Pharmaceuticals of many different therapeutic classes are frequently found in the aquatic 
environment and many of them remain biologically active, altering physiology and impairing  
health of non-target organisms such as fish. NSAIDs and ß-blockers are among those highly 
consumed substances and hence, of high environmental relevance. Mainly based on acute 
toxicity studies, DCF has often been classified as a threat to aquatic wildlife. Few studies 
exist that provide evidence that MTP also cause changes in fish physiology. Long-term 
exposure studies in the environmentally relevant concentration range are still rare for most 
pharmaceuticals. The goal of the present work was to gather information to fill in that gap and 
to assess physiological effects of DCF and MTP on (developing) fish with focus on 
population relevant endpoints, detoxification mechanisms and the potential to disrupt the 
endocrine homeostasis with emphasis on the reproductive system. For reasons of clarity, 
results are initially discussed separately for the in vitro (both substances together) and in vivo 
(substances separated) studies and finally integrated in a short comparative section.   
4.1 In vitro experiments 
Primary hepatocytes are considered to be the closest available in vitro experimental model 
system in terms of normal fish liver physiology (Schmid et al. 2000). They possess all 
benefits of intact cells such as functional organelles and enzyme interactions (Segner 1998) 
and are therefore a valid tool to assess detoxification biomarkers and provide initial 
information on the endocrine activity of test substances (Kloas et al. 1999; Navas and Segner 
2006).  
4.1.1 Detoxification 
Direct effects on the biotransformation in primary hepatocytes of O. niloticus were 
investigated, since the detoxification pathway is mainly located in the liver. It typically 
consists of three major phases and gene expression patterns of key enzymes of these three 
phases were analyzed.  
4.1.1.1 Cytochrome P4501A monooxygenase 
DCF induced biotransformation phase I enzyme CYP1A in primary hepatocytes of 
O. niloticus already at environmentally relevant concentrations of 4x10
-9
 M (about 1 µg L
-1
). 
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However, higher concentrations (4x10
-8
 M and 4x10
-7
 M) did not lead to a statistically 
significant greater induction compared to 4x10
-9
 M. These results suggest that CYP1A is 
moderately involved in DCF metabolism in Nile tilapia. In agreement, after exposure to 
1 µg L
-1
 DCF, Hong et al. (2007) found CYP1A expression to be 9.3-fold increased (in vivo) 
in the liver of Japanese medaka (O. latipes). In contrast, Laville et al. (2004) analyzed the 
effects of different pharmaceuticals including DCF in primary rainbow trout (O. mykiss) 
hepatocytes and fish cell lines by determining cell viability and induction of CYP1A catalytic 
activity (EROD). They found an inhibition of EROD at a concentration of 3.6x10
-5
 M DCF. 
Triebskorn et al. (2004) demonstrated that in vivo exposure to environmentally relevant 
concentrations of DCF led to cellular reactions in various tissues of rainbow trout after 
exposure to < 100 µg L
-1
 (about 4x10
-7
 M). These findings have been interpreted as activated 
stress status, and modifications of the structure of cell organelles as intensified need for 
detoxification capacities. According to Bort et al. (1999) the mechanisms of DCF cytotoxicity 
are not fully understood but there is evidence that CYP-mediated metabolism is also involved 
when human and rat hepatocytes experience acute toxicity. 
 
Based on these findings, DCF seems to be cytotoxic for Nile tilapia hepatocytes already at 
environmentally relevant concentrations. CYP1A is an accepted indicator of cellular toxicity 
and an increase in hepatic CYP1A expression is consistent with the role of the liver in 
xenobiotic metabolism and excretion (Sarasquete and Segner 2000). In comparison to Hong et 
al. (2007), the in vitro response presented in this study resembles the in vivo situation found 
by the authors in terms of sensitivity of the different models, although the increase in CYP1A 
expression was higher in the in vivo system. As stated by Ferreira et al. (2014), concentration 
dependent induction of CYP1A shows that the in vitro approach reflects physiologically 
relevant in vivo situations and should be considered as a reliable tool to assess phase I 
biotransformation enzymes.  
 
In comparison to DCF, induction of CYP1A gene expression levels after MTP exposure was 
statistically significant only at a concentration 100-fold higher (4x10
-7 
M) than the lowest 
concentration. It seems that Nile tilapia is less sensitive towards exposure to MTP compared 
to DCF considering the effects on CYP1A gene expression. Triebskorn et al. (2007) found 
MTP to cause ultrastructural effects, such as collapse of cellular compartmentation and 
glycogen reduction in rainbow trout liver exposed to 1 µg L
-1
 MTP. The authors concluded 
that these structural reactions might indicate the activation of enzymes equivalent to 
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mammalian cytochromes of the CYP family and therefore an induction of biotransformation 
in the fish liver. In humans (Belpaire et al. 1998) and mussels (Contardo-Jara et al. 2010) 
there is good evidence that MTP biotransformation occurs via CYP enzymes as well. Another 
non-selective ß-blocker (propranolol) was also classified as a CYP1A inducer based on a 
study using trout hepatocytes (Laville et al. 2004). 
4.1.1.2  Glutathione-S-transferase 
Like CYP1A, biotransformation phase II enzyme GST was induced due to DCF exposure at 
all concentrations tested. Again, even the environmentally relevant concentration up-regulated 
GST statistically significant compared to the control group. This increase in GST mRNA after 
DCF exposure indicates that phase II biotransformation occurs, most likely further 
metabolizing CYP1A activated DCF. Stepanova et al. (2013) found DCF to change activity of 
GST only at concentrations of 3 mg L
-1 
(1x10
-5
 M) in early life stages of carp (Cyprinus 
carpio) after 30 days of in vivo exposure.  
 
Studies of the effects of MTP on GST gene expression are scarce. In mussels (Dreissena 
polymorpha), phase II enzymes seem to be involved in biotransformation processes of MTP. 
Contardo-Jara et al. (2010) found an increase of piGST mRNA expression after four to seven 
days exposure to 2x10
-7
 M and 2x10
-6
 M MTP and concluded that GST mRNA induction is a 
valid, sensitive tool to investigate the effects of exposure of non-target aquatic organisms to 
environmentally relevant concentrations of PhACs (around 1 µg L
-1
). Apparently, no other in 
vitro data on the effects of DCF and MTP on expression levels of GST in (Nile tilapia) 
primary hepatocytes is available. 
4.1.1.3 Multidrug resistance protein 
DCF exposure induced MDRP gene expression levels up to 3-fold compared to the control 
group. Expression levels tend to increase with elevating concentrations (1.9 to 3.0-fold) but, 
due to high SDs at the higher concentrations, this difference only reached statistical 
significance at a concentration of 4x10
-9 
M. Various authors found evidence that xenobiotics 
induce ABC transporter gene expression in fish, for example due to exposure to 
pharmaceuticals (Corcoran et al. 2012), polycyclic aromatic hydrocarbons (Paetzold et al. 
2009) or heavy metals (Long et al. 2011). Up-regulation of gene expression of ABC 
transporters as found here after DCF exposure could be a response to the presence of DCF 
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and/or its metabolites but further studies would be necessary to confirm this hypothesis at the 
post-transcriptional and protein level. 
 
Activated and conjugated drugs and their metabolites need to be eliminated by the organisms. 
Therefore, it makes sense that an increase of phase I and II enzyme gene expression occurs in 
parallel to an increase of phase III metabolism. DCF and its metabolites seem to be at least 
partly eliminated by MDRP. With respect to MTP, it is likely that other enzymes of the ABC 
superfamily catalyze excretion since the induction of MDRP mRNA was not statistically 
significant different from the control (although expression level was up to 2.7-fold higher). In 
mussels, exposure to ß-blockers (MTP, propranolol) induced P-gp mRNA expression 
(Contardo-Jara et al. 2010; Fabbri et al. 2009). P-gp is known to transport relatively non-
specific xenobiotic compounds and their metabolites (Smital et al. 2003). However, Caminada 
et al. (2008) found MTP and propranolol to have no or an inhibitory effect on P-gps in the 
fish cell line PLHC-1.  
 
According to Leslie et al. (2001), MDRP supports the maintenance of the cellular redox status 
and therefore the cellular GSH homeostasis by transporting glutathione (GSH) or glutathione 
disulphide (GSSG). GSH has many important roles in the protection of cells from oxidative 
stress. Since none of the substances tested caused a huge increase in MDRP mRNA, it seems 
unlikely that the substances cause oxidative stress in Nile tilapia hepatocytes. 
4.1.2 Vitellogenin 
VTG induction can be measured in fish hepatocytes in vitro and has been suggested as a 
useful tool for screening of endocrine disruption potential concerning estrogenicity (Navas 
and Segner 2006). EE2 was included in the experimental design as a substance well-known to 
cause estrogenic action by binding to estrogen receptors. The concentration of 1x10
-6
 M 
induced VTG gene expression statistically significant compared to the control group. EE2 
exposure led to a 2.0-fold increase in VTG gene expression. The effect therefore ranged 
between a DCF exposure of 4x10
-8 
M (1.4-fold) and 4x10
-7 
M (3.0-fold) and caused a higher 
induction than any of the MTP concentrations.  
 
VTG gene expression was up-regulated in a dose-dependent manner after exposure to DCF, 
although only the lowest and highest concentrations were statistically significant different 
from the control group. Many pharmaceuticals are known to have the potential to promote 
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estrogenic activities (Kloas et al. 2009) and different studies provide evidence that DCF is one 
of them. In vivo, Hong et al. (2007) found an increase of VTG gene expression in male 
medaka of 46.6-fold at 1 µg L
-1
 DCF and of 179.5-fold at 8 mg L
-1
 DCF after four days of 
exposure. The authors concluded that DCF has an estrogenic potential, likely to cause 
endocrine disruption in fish.  
 
MTP induced VTG mRNA between 1.2 and 1.6-fold, while the difference was only 
statistically significant at 4x10
-8
 M. Massarsky et al. (2011) reviewed the potential effects of 
human ß-blockers on aquatic organisms and found species-specific endocrine disruption. 
Huggett et al. (2002) showed that plasma E2 was significantly increased in male medaka after 
two weeks of propranolol exposure at all concentrations tested. 
4.2 In vivo DCF exposure  
Conducting an in vivo experiment is one of the most comprehensive approaches to mimic 
natural conditions in the laboratory. Certain advantages appear since, for example, control 
groups can be included in the experimental design and physico-chemical conditions can be 
easily controlled. Nonetheless, laboratory experiments are always run in rather artificial 
environments. 
4.2.1 General and morphological parameters 
Two main population relevant endpoints, namely hatching success and survival after 80 dph, 
were not impaired by DCF exposure at any treatment concentration (4x10
-10
 M to 4x10
-7
 M). 
In general, O. niloticus was found to be transiently most sensitive to exposure treatment 
between 8 to 30 dph of exposure, thus in the passage from yolk sac feeding to free swimming 
and free feeding state. Differences between the sensitivity of the embryonic developmental 
stages of fish and juvenile/adult individuals of the same species could be due to the improper 
developed enzymatic systems, differences in metabolism pathways or different processes of 
absorption of substances into organisms (van Leeuwen et al. 1985) and therefore emphasize 
the validity of chronic exposure studies, covering different developmental stages.  
 
Ibuprofen, another NSAID, caused a statistically significant decrease in egg production, 
reduced hatchability and increased embryo mortality in zebrafish (Danio rerio) exposed to   
1-10 µg L
-1
 for only 21 days. As emphasized by Overturf et al. (2015), different fish species 
possess different sensitivities to pharmaceutical exposure. After 8 and 30 dph, growth (neither 
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wet weight nor length) was not affected by DCF exposure, but after 80 dph there was a slight 
reduction in fish growth due to exposure to 4x10
-8
 M DCF. IGF-I gene expression showed the 
same tendency to decrease with increasing DCF concentrations, although not confirmed by 
statistical evaluation. Additionally, the CI was reduced after 30 dph exposure to 4x10
-8
 M 
DCF. However, these results showed no distinct dose-dependency. The calculated HSI 
showed the tendency to increase dose-dependently after 30 dph but no remaining trend was 
found after 80 dph. Thus, one may speculate that the juvenile tilapia after 80 dph might 
somewhat better cope with DCF exposure compared to 30 dph by having a higher developed 
detoxification system, which might need some energy diminishing in turn a bit growth. Lee et 
al. (2011) exposed Japanese medaka for three month to concentrations of                               
1-10,000 µg L
-1
 DCF and did not find any change in HSI as in this study after 80 dph. In 
contrast, Guiloski et al. (2015) found a reduction in fish liver size, revealing a reduced HSI, 
after six weeks of trophic exposure to 0.2 µg kg
-1
 DCF in Tiger fish (Hoplias malabaricus). 
However, higher doses (2 and 20 µg kg
-1
 DCF) had no statistically significant effect though. 
The authors concluded that the reduced HSI could be due to a depletion of glycogen in the 
hepatocytes as found by Triebskorn et al. (2004) in rainbow trout but trophic exposure is not 
the natural exposure route of DCF for fishes and thus is hardly comparable to aqueous 
exposure. Hepatocytes growth can be affected by changes in the function of these cells when 
exposed to NSAIDs (Flippin et al. 2007). Ultrastructural examination showed that DCF 
induced cellular reactions indicating an activated hepatic metabolism in the trout liver already 
after exposure to 1 µg L
-1
 (Triebskorn et al. 2004). Furthermore, mRNA expression of GH 
tended to increase with elevating DCF concentrations. Pickering et al. (1991) found 
circulating levels of GH in rainbow trout after chronic stress of low oxygen levels to increase 
significantly and linked these to an elevation of plasma cortisol in the same fish. GH is 
considered to be a stress-related hormone in fish and exposure to environmentally important 
pollutants, including xenoestrogens, can affect GH mediated mechanisms (Deane and Woo 
2009). Hence, the increase in GH found in this study could be an indicator for stress induction 
in Nile tilapia due to DCF exposure but confirmation by further analyses of e.g. plasma 
cortisol levels is necessary to confirm the non-significant finding. 
4.2.2 Histopathological alterations 
The impacts of pharmaceutical exposures on gill physiology are of special interest, since 
adverse alterations of gills most likely affect oxygen supply and hence all biochemical 
reactions depending on oxygen (Hoeger et al. 2005). Nonetheless, technical guidelines for the 
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preparation and histopathological evaluation of fish organs other than gonads, that would 
increase the comparability of different study results, are still missing (Memmert et al. 2013) 
but of urgent need as shown by Wolf et al. (2014). The authors re-evaluated three previously 
published studies of DCF exposure in trout (Hoeger et al. 2005; Mehinto et al. 2010; 
Memmert et al. 2013) concerning their histopathological outcomes. They applied a pathology 
peer review/pathology working group model known from mammalian toxicologic pathology. 
Briefly, this means that besides the study pathologist another, reviewing pathologist, evaluates 
the histopathological alterations while knowing the outcome of the first evaluation (for more 
details see Wolf et al. 2014). Aim of this re-evaluation was to reconcile the previous 
mentioned differences in study results and to establish an appropriate NOEC of DCF based on 
histopathology which was set to be >320 µg L
-1
 afterwards. Unfortunately, the study by 
Schwaiger et al. (2004) could not be re-evaluated due to missing material and overall, the 
quality of the re-evaluated material was judged to be rather fair. Based on the re-evaluation, 
histopathological effects of environmentally relevant concentrations of DCF on organs of 
trout species seem unlikely. 
 
Nonetheless, histopathological changes of SLs in O. niloticus gills after DCF exposure were 
found and mainly characterized as mild, only epithelial lifting also occurred notably in a 
severe manner. Overall, epithelial lifting (including formation of edema) and proliferation of 
epithelial cells (hyperplasia) were the most dominant findings. As stated by Wolf et al. 
(2015), especially epithelial lifting is susceptible to occur as an artifact during sampling and 
fixation process. To reduce handling biases, it was suggested to pay special attention to the 
procedures that take place at or around the time of death and to use Bouin´s solution for 
fixation. In the present study, experimental fish of the control group were treated the same 
way than fish of the DCF exposure groups and Bouin´s solution was used. Therefore, 
provisions were made against the occurrence of artifact. The rather severe occurrence of 
epithelial lifting is in agreement with other study results (Schwaiger et al. 2004; Triebskorn et 
al. 2004; Monteiro et al. 2008) and indicates an impaired osmoregulation due to damaged 
epithelia (Wood 2001), further confirmed by the occurrence of hypertrophy in chloride cells. 
Proliferation of epithelial cells is a common result of chronic sub-lethal xenobiotic exposure 
(Mallat 1985; Wood 2001) and in combination with the proliferation of chloride and mucous 
cells, seen as an adaptation mechanisms to reduce the uptake by increasing the blood-water 
diffusion distance (Wood 2001). Unexpectedly, proliferation of mucous/chloride cells was 
found more often in the control group than in the two lowest exposure treatments. 
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After 21 days exposure to 50 µg L
-1
 DCF, Hoeger et al. (2005) found a statistically significant 
increase of lamellar clubbing, while epithelial cell hyperplasia, thickened lamellar tips and 
secondary lamellar fusion were only occasionally observed. Immunohistology revealed an 
increase of granulocyte numbers in the primary gill filaments. According to the authors, the 
infiltration of granulocytes may support the presence of inflammatory processes, possibly in 
response to the damage of vascular endothelium. Leucocyte infiltration was observed rather 
seldom in the control group and after 4x10
-7
 M DCF exposure. Only one sample of the 
highest exposure group had leucocytes present (with the highest number of leucocytes found 
at all), while all other replicates did not show this alteration. Almost all samples of the other 
exposure groups showed leucocyte infiltration though. These results could reflect the anti-
inflammatory mode of action of DCF in fish at certain exposure concentrations. Schwaiger et 
al. (2004) calculated a mean assessment value (MAV) based on three grades of 
histopathological alterations in the gills of trout and this value was already highly 
significantly different than the control group after 28 days exposure to 5 µg L
-1
 DCF.  
 
The findings of Wolf et al. (2014) raise concern about the general reliability of 
histopathological changes published and emphasize the need of good scientific practice and 
documentation. In combination with the findings of this study they also shown that exposure 
studies should cover a variety of fish species since fish are a taxonomic diverse group adapted 
to different environmental conditions and therefore, it is likely that they posses different 
sensitivities.  
 
Endpoints discussed so far (morphologically as well as molecular biologically) indicate only 
slight impacts of DCF exposure on Nile tilapia, mostly missing a clear dose-dependency. 
Only histopathological alterations showed clear but rather mild to moderate effects.  
4.2.3 Gene expression of pituitary gonadotropins and hepatic vitellogenin 
In contrast, effects of DCF exposure on reproduction related endpoints and estrogenicity were 
more pronounced. Gene expression of LH was reduced almost dose-dependently after 80 dph 
of DCF exposure. LH stimulates the testosterone production via the HPG axis (Milla et al. 
2009) and a reduced expression pattern interferes with the normal sex development. 
Therefore, a decrease in LH gene expression can be considered as an indicator of the 
endocrine activity of DCF, further confirmed by findings of Fernandes et al. (2011) who 
demonstrated an interference with the sex steroid synthesis due to DCF exposure in common 
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carp (C. carpio). Vajda et al. (2011) exposed adult male fathead minnows (P. promelas) to the 
effluents of a wastewater treatment plant containing pharmaceuticals and found a 
demasculinization of the test organisms. Furthermore, a non-monotonic dose response 
relationship (NMDR) of VTG gene expression was found with an inverted U-shape due to 
DCF exposure, peaking at 4x10
-9
 M, which was nearly mirrored by the LH and FSH patterns, 
suggesting negative feedback mechanisms of DCF on pituitary gonadotropins via an 
estrogenic mode of action. The maximal response was observed at an intermediate dose, 
highlighting the general need for low-dose testing in ecotoxicological research. In case of 
NMDRs a safe dose determined from high doses does not guarantee safety at lower, untested 
doses (Vandenberg et al. 2012). In male medaka, Hong et al. (2007) found an increase of  
VTG gene expression of 47-fold at 1 µg L
-1
 and 180-fold at 8 mg L
-1
 DCF and in male 
Xenopus laevis, Efosa et al. (in. prep., pers. comm.) found a dose-dependent induction of 
VTG gene expression of about 2-fold after eight days exposure to 10
-10
 M and 10
-8
 M DCF. 
Furthermore, the authors could show that DCF exposure caused estrogen-like behavioral 
effects in male X. laevis and, based on these findings, concluded a light to moderate 
estrogenicity of DCF in amphibians. Overall, VTG gene expression analysis is a valid tool to 
study the endocrine disruption potential concerning estrogenicity of pharmaceuticals (Navas 
and Segner 2006) and taking the different studies with various organisms into account, DCF 
seems to possess estrogenic endocrine disruption potential. As reviewed by Overturf et al. 
(2015), reproductive effects of NSAIDs tend to vary between experiments and species and 
overall, the effects of prostaglandin inhibition in fish on reproductive success remain unclear.  
4.2.4 Detoxification 
Data obtained in vitro indicated that DCF is metabolized through a CYP1A-GST-MDRP 
route in O. niloticus primary hepatocytes (Gröner et al. 2015). These enzymes were found by 
different authors to be involved in the detoxification metabolism of pharmaceuticals (e.g. 
Hong et al. 2007; Contardo-Jara et al. 2010; Corcoran et al. 2012) and an induction was also 
found in vivo in this study. Combining VTG gene expression data with mRNA expression 
data of these key enzymes of the biotransformation pathway, it seems likely, that an increased 
metabolism and excretion (with exception for 4x10
-7
 M DCF) is jointly responsible for the 
inverted U-shaped response in VTG mRNA expression. At the higher concentrations the 
detoxifying biotransformation might be more efficient to metabolize and excrete DCF, which 
in turn might lead to a lower availability of DCF acting as an estrogenic EDC in tilapia. At   
4x10
-8
 M DCF, MDRP gene expression was induced about 5-fold, while VTG gene 
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expression was reduced by almost 50 % compared to the previous concentration. No clear 
reason for the performances at the highest concentration (4x10
-7
 M DCF) can be given, but 
further adverse side effects or adaptation to uptake, metabolization, and/or excretion of DCF 
as well as general impairment effects could be possible. Histopathological examinations of 
liver tissue would give further indication.  
 
Gene expression patterns of CYP1A and GST were also analyzed in gill samples. The gills 
are the primary site of exposure to waterborne chemicals and hence, knowledge of their 
potential to metabolize xenobiotics is important to predict resulting plasma concentrations and 
downstream biological effects (Bartram et al. 2012). They are one main biological barrier in 
direct contact with environmental pollutants and known to exhibit biotransformation enzymes 
(Hong et al. 2007). CYP1A was not statistically significant altered by DCF exposure in gills 
but showed some tendency to decrease with increasing DCF concentrations. This is in 
contrast to findings of Hong et al. (2007) who found an induction of  CYP1A in gills of 
Japanese medaka after exposure to 1 µg L
-1
 DCF. Mehinto (2009) also found an increase in 
CYP1A1 relative expression in gills of rainbow trout at 0.5 µg L
-1
 DCF, with a maximum up-
regulation of less than 2-fold. On the other hand, GST was initially induced with increasing 
DCF concentrations (statistically significant for 4x10
-9
 M DCF) but the two highest 
concentrations showed a distinct reduction compared to the other treatment groups. These 
results might indicate that at lower DCF concentrations biotransformation processes in gills 
are increasingly active but higher DCF concentrations might already cause cellular damage as 
indicated by histological examinations. Unlike the liver, gills are in direct contact to the 
surrounding pharmaceutical concentrations and therefore, impairment might occur already at 
lower concentrations than in the liver. In gills, it seems that exposure to 4x10
-8
 M DCF 
reduces gill functionality already and therefore gene expression of GST was reduced.  
4.2.5 Oxidative stress 
As an unspecific measure for oxidative stress, TBARS levels in three different tissues were 
determined. Gill and muscle samples showed no differences in TBARS level after DCF 
exposure but in brain samples a statistically significant increase was found due to             
4x10
-8
 M DCF. Saucedo-Vence et al. (2015) found a statistically significant increase of LPO 
compared to the control in gills, muscle and brain of common carp after exposure to around 
7 mg L
-1
 DCF for 24 days. Comparing these values to the LPO level after four days of 
exposure, the authors found a decrease in muscle and brain tissue and an increase only in gill 
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tissue. Stepanova et al. (2013) found a statistically significant reduction in TBARS levels in 
whole body samples of embryos and larvae of common carp after 30 days of exposure to 0.03, 
1 and 3 mg L
-1
 DCF. In zebrafish embryos, Feito et al. (2012) also found a reduction in LPO 
after 90 min of DCF exposure (0.03 µg L
-1
) and the authors conclude that their results are in 
agreement with the protective effects of NSAIDs against oxidative stress as mentioned by 
Petersen et al. (2005). Taking the different results into account it seems that LPO and TBARS 
level evaluations are rather cautious to interpret and the single increase in TBARS level in 
brain tissue found in this study should not be overestimated. Based on these findings, it seems 
most likely that DCF at environmentally relevant concentrations does not cause oxidative 
stress in Nile tilapia. Gene expression analyses of enzymes involved in oxidative damage 
defense such as CAT or GPx would give further indication.  
4.3 In vivo MTP exposure  
So far, only few studies are available investigating long-term effects of ß-blockers in fish and 
most toxicity studies were conducted with concentrations exceeding those expected in the 
aquatic environment. Furthermore, most studies with ß-blockers have focused on propranolol, 
a non-specific, very lipophilic ß-blocker. Thus, data gained in this study were mostly 
compared with studies using ß-blockers other than MTP.  
4.3.1 General and morphological parameters 
For MTP, van den Brandhof and Montforts (2010) found the NOEC at 12.6 mg L
-1 
in a fish 
embryo toxicity test with zebrafish. Concentrations as high as 50.5 mg L
-1
 MTP impaired 
hatching and growth. Results of the study presented here show that chronic exposure to 
environmentally relevant concentrations of MTP had no effect on hatching success and 
survival in O. niloticus. This is in agreement with findings of Lorenzi et al. (2012). Exposure 
to 0.1-10 µg L
-1
 propranolol for 21 days did not affect hatchability and time to hatch in 
fathead minnows. In contrast, growth impairments already occurred at low MTP 
concentrations in this study. Fish wet weight was reduced dose-dependently after 30 and 
80 dph exposure from 4x10
-10
 M to 4x10
-7
 M MTP. Length was less clear affected by MTP 
exposure but also dose-dependently reduced after 30 dph. Surprisingly, these observations 
were not confirmed by gene expression analyses of pituitary GH and hepatic IGF-I. These 
two main biomarkers of somatic growth did not show any changes in expression patterns due 
to MTP exposure. Additionally, the CI was only statistically significant reduced after 80 dph 
comparing 4x10
-10
 M (highest CI) and 4x10
-7
 M MTP (lowest CI). Propranolol caused a 
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reduction in fish growth after 14 days exposure to 500 µg L
-1
 in medaka and the number of 
viable eggs that hatched were decreased already at 0.5 µg L
-1
 (Huggett et al. 2002). Owen et 
al. (2009) exposed juvenile rainbow trout to sub-lethal levels of propranolol and found a 
statistically significant reduction of growth during a ten days exposure treatment to 10 mg L
-1
 
but also a possible adaptation mechanism as growth recovered with time. In mussels, ten days 
of propranolol exposure (147 µg L
-1
) significantly inhibited the feeding rate (Solé et al. 2010). 
Cardiovascular dysfunction is one possible consequence of exposure to ß-blockers leading to 
impaired fitness expressed in reduced growth and fecundity (Owen et al. 2007). Triebskorn et 
al. (2007) analyzed cellular effects in rainbow trout after exposure to 1-100 µg L
-1
 MTP for 
28 days and the authors stated that the structural changes found could be a response to 
compensate for a reduced supply with oxygen and nutrients, which could in turn lead to 
reduced growth. Catecholamines are important for the mobilization of energy reserves to 
ensure tissue metabolism during (acute) stress by stimulating gluconeogenesis and 
glycogenolysis in the liver (Fabbri et al. 1995). If the relevant receptors are blocked (e.g. by 
MTP), the mobilization could be inhibited. On the other hand, Winter et al. (2008) exposed 
fathead minnows to atenolol (0.1-10 mg L
-1
), another selective ß1-blocker, and after 28 days 
no significant effects on viability, hatching or growth were found in larval fish. 21 days 
exposure of adult fish had almost the same outcome. In a follow up study, Giltrow et al. 
(2009) exposed fathead minnows to propranolol (0.001-10 mg L
-1
) and found mortality and 
health affected during the first days of the exposure experiment. Taken together, conclusions 
on the fish toxicity of ß-blockers based on the before mentioned endpoints are mixed and 
remain somehow unclear. 
 
Calculated HSI did slightly increase with increasing MTP concentrations after 80 dph of 
exposure but differences were not statistically significant. Bartram et al. (2012) exposed 
rainbow trout to 1 mg L
-1
 propranolol and did not find a difference in HSI between control 
and exposed animals neither. The authors also found a general decrease in HSI over the 
duration of the experiment, as found in Nile tilapia here, and hypothesized that a deprivation 
of food as found by Metón et al. (2003) could be the reason. The authors linked a reduced 
liver size to various hepatic changes in gilthead seabream (Sparus aurata) including 
alterations of enzymatic pathways and glycogen levels. Still, no effect of the pharmaceutical 
treatment was observed. The HSI is only a rough measure for the impacts of pollutants 
leading to liver growth but if the HSI is almost not changed due to pharmaceutical exposure, 
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it can be seen as an indicator for rather low toxicity. Again, examination of liver 
histopathology would give further indication on the toxicity potential.  
4.3.2 Histopathological alterations 
Exposure to MTP did not affect the number of SLs with histopathological alterations in gills 
of O. niloticus after 80 dph. In fact, 4x10
-9
 M MTP and higher concentrations even showed 
slightly less affected gills and only proliferation of mucus and chloride cells increased dose-
dependently. Additionally, infiltrated leucocytes were found significantly more often at    
4x10
-7
 M MTP compared to the control group. Overall, only mild alterations occurred in a 
notable amount. These findings are in accordance with findings by Triebskorn et al. (2007). 
Exposure to similar MTP concentrations in rainbow trout for 28 days caused only little 
reactions in gills and no clear concentration-effect relationships were found. Epithelial lifting, 
hyperplasia and hypertrophy of mucus and chloride cells were detected. Avella et al. (1999) 
could show that an in vitro exposure of sea bass (Dicentrarchus labrax) gill cells to 
propranolol blocked the secretion of chloride ions, likely affecting ion regulation in the whole 
fish. Overall, chronic exposure to environmentally relevant concentrations of MTP affects gill 
integrity of O. niloticus only mild and based on this endpoint, the risk seems to be relatively 
low. 
4.3.3 Gene expression of pituitary gonadotropins and hepatic vitellogenin 
Gene expression patterns of the gonadotropins LH and FSH were quite similar after MTP 
exposure. 4x10
-10
 M MTP caused the highest relative expression value und there was a non-
significant decrease with increasing concentrations of MTP compared to the control 
afterwards. Sex steroid levels in Japanese medaka were altered after 14 days of exposure to 
propranolol (1-500 µg L
-1
). The level of testosterone was significantly reduced in male fish, 
whereas E2 levels were significantly increased in both sexes (Huggett et al. 2002). The 
authors hypothesized that an increased aromatase activity due to the pharmaceutical exposure 
could be the reason (not tested though). Furthermore, the findings indicate a modified sex 
steroid regulation. A reduced LH mRNA as found in O. niloticus here would also likely lead 
to a reduced testosterone production via the HPG axis (Milla et al. 2009), confirming the 
results of Huggett et al. (2002). Further direct measurements of sex steroid levels in blood 
plasma and aromatase activity on the transcriptional level would help to find more 
mechanistic explanations for the results gained.  
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VTG gene expression data complemented the results. Low concentrations of MTP caused 
only a very little induction of VTG mRNA, only 4x10
-7
 M MTP led to a statistically 
significant increase. Therefore, MTP seems to have the potential to alter endocrine processes 
but only at concentrations at least 100-fold of the environmentally relevant one in 
O. niloticus. As reviewed by Massarsky et al. (2011), exposure to ß-blockers (mainly 
propranolol and MTP) affected reproduction, growth, heart rate and hepatic glycogen stores in 
some fish species. These findings indicate the potential of ß-blockers to acts as EDCs, further 
strengthened by findings of altered sex hormone levels and delayed embryonic development 
(Owen et al. 2007). Nonetheless, no data on VTG induction in fish due to MTP exposure is 
available and direct measures of the endocrine disrupting mode of ß-blockers are rare. Taken 
together, exposure to environmentally relevant concentrations of MTP has rather mild effects 
on endpoints discussed in this section.   
4.3.4 Detoxification 
MTP exposure caused no statistically significant changes in mRNA levels of CPY1A, GST or 
MDRP in O. niloticus at any sampling point. After 80 dph, CYP1A and MDRP showed the 
tendency to increase with increasing concentrations though. Overall, SDs were quite high in 
theses data, potentially masking effects. So far, there is good evidence in the literature that 
CYP1A is involved in the detoxification of ß-blockers in fish (Laville et al. 2004; Bartram et 
al. 2012) but also in mussels (Contardo-Jara et al. 2010). Even indirect measures indicated 
this. The structural reactions of the endoplasmic reticulum (severe vesiculation and dilation) 
found by Triebskorn et al. (2007) in cellular areas adjacent to the hepatic vessels of rainbow 
trout might indicate an activation of enzymes similar to mammalian cytochromes of the CYP 
family and therefore an induction of biotransformation mechanisms in the fish liver. Sun et al. 
(2015) analyzed the transcriptional responses of adult zebrafish exposed to propranolol and 
MTP (0.03-3 mg L
-1
) concerning a great variety of genes involved in the detoxification 
pathways and stress response. Other enzymes were chosen though. In the liver, the authors 
only found an induction in the expression of hsp70 in male fish, no enzyme involved in 
detoxification was induced. In marine mussels, propranolol induced phase I metabolism 
(based on carboxylesterase) statistically significant at 147 µg L
-1
 but GST was reduced 
compared to the control when exposed to 11 µg L
-1
. The higher exposure concentrations then 
led to an increase again (Solé et al. 2010). In the digestive gland of freshwater mussels, no 
statistically significant effects of seven days of MTP exposure (2x10
-9
 M to 2x10
-6
 M) on 
GST gene expression level were found by Contardo-Jara et al. (2010). Concerning the third 
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phase of the biotransformation pathway most likely other enzymes than MDRP are involved 
in the excretion of ß-blockers. Data in fish are almost missing but in mussels P-gps were 
found to be active after ß-blocker exposure (Fabbri et al. 2009; Contardo-Jara et al. 2010). 
Combining the results, it seems that environmentally relevant concentrations of MTP (and 
other ß-blockers) have only little effects on the hepatic detoxification mechanisms in fish. 
 
In gills of O. niloticus, no clear pattern was found in gene expression of CYP1A and GST 
after 80 dph of MTP exposure, too. It seems likely that detoxification of MTP did not occur 
via the enzymes under investigation. Since histopathological examination did not reveal 
severe damages of gill tissue other reason such as cytotoxicity or adverse side effects seem 
unlikely. Bartram et al. (2012) exposed rainbow trout to propranolol  in vivo (1 mg L
-1
) and in 
vitro (0.1-400 µg L
-1
) and analyzed EROD activity (as an indicator for CYP1A activity) in gill 
and liver samples. In vivo, gill EROD activity was statistically significant affected by 
propranolol and liver samples showed a similar pattern, but non-significant. Environmentally 
relevant concentrations (0.1 µg L
-1
) did not statistically significant induce gill or liver EROD 
activity in vitro though, but higher concentrations (200 µg L
-1
, equivalent to 'normal' human 
therapeutic level) did. GST gene expression was statistically significant enhanced after four 
and seven days of exposure to MTP (2x10
-7
 M and 2x10
-6
 M) in freshwater mussel 
D. polymorpha, indicating biotransformation processes (Contardo-Jara et al. 2010). In marine 
mussel (Mytilus galloprovincialis), Solé et al. (2010) found a 1.4-fold increase in gill GST 
expression at a low propranolol (11 µg L
-1
) concentration, too. Since further data in fish are 
missing, one can only speculated that detoxification of xenobiotics in gills of vertebrates and 
invertebrates might be implemented differently.  
4.3.5 Oxidative stress  
In brain and muscle tissue of O. niloticus, a statistically significant increase in TBARS level 
compared to the control was found due to exposure to 4x10
-10
 M and 4x10
-8
 M MTP. In gills, 
no effect was observed. Sample processing was performed at different days and maybe 
handling issues could give some explanation for these findings (although not found in gills). 
Furthermore, different responses of organs might be due to different anti-oxidant capacities of 
the tissues as suggested for the digestive gland and gills in mussels (Solé et al. 2010). Sun et 
al. (2015) exposed adult zebrafish to propranolol and MTP (0.03-3 mg L
-1
) and analyzed the 
transcriptional response of different tissues (brain, liver, gonads) concerning the antioxidant 
system. Both substances induced the transcriptional response of the antioxidant enzymes 
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(including CAT and GPx) dose-dependently in both sexes in tissues other than brain. In 
invertebrates, MTP (2x10
-7
 M and 2x10
-6
 M) induced mRNA levels of SOD and CAT 
statistically significant in the digestive gland but not in the gills of freshwater mussels 
(Contardo-Jara et al. 2010). In contrast, propranolol exposure (11 µg L
-1
 and 147 µg L
-1
) 
resulted in elevated LPO damage in the gills of the marine mussel M. galloprovincialis but no 
evidence for oxidative stress in the digestive gland was found based on CAT and LPO 
analyses (Solé et al. 2010). To gain more certainty about the effects of MTP exposure on the 
oxidative stress status in O. niloticus, gene expression analyses of certain enzymes such as 
CAT and SOD would be useful. These could then be compared to available data in other taxa. 
4.4 In vitro versus in vivo preparation 
The studies presented here enable a direct comparison of the impacts of pharmaceutical 
exposure on the detoxification pathway in fish between in vitro and in vivo preparations. Due 
to DCF exposure, in vitro and in vivo gene expression analyses of three key enzymes 
(CYP1A, GST and MDRP) of the detoxification pathway showed similar patterns, although 
some differences occurred. The sensitivity of both approaches seems to be comparable, 
although the increase of CYP1A expression was not statistically significant in vivo but in 
vitro. For GST gene expression, a higher increase in vitro (up to 4.3-fold) was found while for 
MDRP the highest increase was found in vivo (almost 5-fold). The most prominent difference 
was found at the highest DCF concentrations (4x10
-7
 M). In vitro, all three genes possessed 
their highest expression level at this concentration while in vivo, the expression decreased 
compared to the second highest concentration. Hypothetically, additional adverse side effects, 
cell damage or general impairment effects or even adaptation mechanisms could be an 
explanation. At least, these results indicate that some differences remain when using an in 
vitro or in vivo preparation for exposure studies.  
 
In contrast, comparing the gene expression patterns of the in vitro and in vivo experiments 
after MTP exposure, less similarities appear. While in vitro, CYP1A and GST were 
statistically significant induced due to MTP exposure, no such significance was found in vivo. 
Nonetheless, 4x10
-7
 M MTP caused a statistically significant increase of CYP1A mRNA in 
vitro and in vivo the same concentration caused the highest increase of about 3.6-fold 
compared to the control group as well. Due to high SDs, the increase was non-significant 
though. In vitro GST gene expression was almost twice as high as in vivo but MDRP 
expression levels were comparable between both approaches. Overall, induction of these 
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detoxification enzymes was rather low and it seems likely that MTP is mainly metabolized 
through another pathway than investigated.  
 
Concerning the metabolic capability of O. niloticus one can derive from the results presented 
that an in vitro approach is as informative as an in vivo preparation and in terms of animal 
welfare the first mentioned is to favor. This is in accordance with findings of Bartram et al. 
(2012). The authors exposed trout to propranolol and analyzed EROD activity in vitro and in 
vivo in gill and liver tissue. In the gills, the in vitro EROD induction was generally higher 
than in vivo at similar concentrations, whereas in liver tissue, the induction rate was similar, 
but only over the initial 24 h of exposure. When comparing rates directly, the authors did not 
find differences in the EROD activity of the control group between the two approaches. They 
concluded that in vitro preparations could be used as in vivo surrogates to study the metabolic 
capability of fish after exposure to xenobiotics, including pharmaceuticals.  
 
Regarding VTG gene expression, almost the same pattern and level of sensitivity after MTP 
exposure in vitro and in vivo were found but due to DCF exposure, VTG gene expression 
occurred differently. There was a statistically significant increase due to 4x10
-9
 M DCF in 
both preparations. While the increase found in vitro was almost dose-dependently, ranging 
from 1.3-fold to 3-fold, VTG gene expression increased in vivo in a NMDR relationship, with 
a distinct peak at 4x10
-9
 M DCF, leading to an inverted U-shape expression pattern. Overall, 
the increase was 1.5 to 3.8-fold and therefore comparable with the in vitro results. Concerning 
VTG gene expression and therefore the estrogenic mode of action of DCF and MTP, 
differences between the in vitro and in vivo preparations occurred. These results illustrate that 
in vivo experiments are necessary to demonstrate the actual relevance of an exposure. Only in 
vivo, all biological effects on the physiology, including detoxification, are taken into account, 
and therefore other physiological responses of the whole organisms are found. 
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5 Conclusions and perspectives 
Changing (aquatic) environments, naturally or mediated by human activities, challenge the 
organisms living therein and force them to adapt to altered conditions continuously. The 
physiological responses, meaning the automatic, instinctive reactions to a stimulus, help the 
organisms to adapt and survive. Furthermore, they can be examined and be used as indicators 
for the risks possessed by certain pollutants. Overall, chronic exposure experiments lead to a 
more realistic risk assessment than acute toxicity tests. The latter often indicate no or very low 
risk due to very high no observed effect concentrations (NOEC) values that exceed 
pharmaceutical concentrations found in the aquatic environment. The in vitro and in vivo 
studies presented here illustrate valid reasons for the need of chronic, low-dose testing in 
ecotoxicological research. First of all, some adverse impacts of the pharmaceuticals tested 
were already found at environmentally relevant concentrations (around 4x10
-9
 M). Although 
hatching and survival, two comprehensive indicators for harmful conditions, were not 
affected, it was shown that various endpoints were affected that could be of relevance for the 
population´s viability long-term. Secondly, larvae and juvenile/adult fish were found to 
possess different sensitivities to certain endpoints and only chronic studies can cover different 
developmental stages. Finally, non-monotonic dose response relationships can occur (as 
found for VTG after DCF exposure in vivo) and therefore, safe doses cannot always be 
determined from high doses (Vandenberg et al. 2012). 
 
Concerning the DCF exposure, the results presented here revealed that 
(1) in vitro already environmentally relevant DCF concentrations induced the 
detoxification and gene expression of CYP1A, GST and MDRP almost dose-
dependently.  
(2) VTG up-regulation in vitro demonstrated the estrogenic potential of DCF.  
(3) in vivo no negative effects on hatching success and survival were found. Growth was 
mildly reduced after 80 dph of exposure, reflected by a non-significant reduction in 
IGF-I gene expression.  
(4) DCF exposure in vivo caused mild to moderate changes in gill histology and occurring 
alterations might increase the blood-water diffusion distance and reduce uptake of the 
xenobiotic.  
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(5) DCF exposure in vivo altered gonadotropin and VTG gene expression indicating its 
estrogenic endocrine activity (Figure 44) 
(6) DCF detoxification in vivo was at least partly catalyzed by a CYP1A-GST-MDRP 
enzyme route in liver tissue. In gills, there was evidence that the highest DCF 
concentrations caused cellular damage reducing the detoxification capability and/or 
other enzymes were more active.  
(7) TBARS levels in vivo were mildly elevated in brain tissue but not in gills and muscles, 
and therefore the oxidative stress response seems tissue-specific and the risk relatively 
low. 
 
Concerning MTP exposure, the results presented here revealed that 
(1) in vitro detoxification was only moderately induced due to MTP exposure. Only 
CYP1A and GST induction was statistically significant.  
(2) a mild increase in VTG mRNA in vitro demonstrated a potential estrogenic mode of 
action of MTP. 
(3) in vivo hatching success and survival were not affected by MTP exposure but growth 
was reduced dose-dependently after 30 and 80 dph, respectively. 
(4) MTP exposure in vivo caused mild histopathological alterations, mainly proliferation 
of mucous/chloride cells were found. 
(5) in vivo the lowest MTP concentration increased LH and FSH mRNA but higher 
concentrations reduced gene expression. VTG gene expression was induced at the 
highest MTP concentration and taken together, these results indicate that MTP can 
alter endocrine regulated processes at certain, relatively high, concentrations      
(Figure 44).  
(6) in vivo enzymatic activities of CYP1A, GST and MDRP were low and it seems likely 
that other enzymes are involved in the detoxification of MTP in O. niloticus liver and 
gill tissue.  
(7) TBARS levels in vivo were elevated in brain and muscle tissue indicating that MTP 
has the potential to cause tissue-specific oxidative stress.  
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Figure 44. Summary of the effects of diclofenac (DCF) and metoprolol (MTP) on the hypothalamus-
pituitary-gonad (HPG) axis of Oreochromis niloticus. DCF directly affects synthesis of the pituitary 
gonadotropin luteinizing hormone (LH) while MTP also affects the follicle stimulating hormone 
(FSH) but overall less distinct. Both substances induced hepatic vitellogenin (VTG) synthesis but 
MTP only at higher concentrations compared to DCF. : inhibition, : induction, GnRH: 
gonadotropin releasing hormone, arom: aromatase. 
 
 
The recent results show that fish possess different targets with different levels of sensitivity 
concerning exposure to pharmaceuticals such as DCF or MTP. As promoted elsewhere, 
comprehensive studies should link different relevant endpoints since effective concentrations 
differ. Furthermore, in future studies the gender of fish should be considered when assessing 
effects of pharmaceuticals. Not only tissue-specific responses occur, as found in the studies 
presented, but also gender-specificity might appear. In humans, variations in the metabolism 
of pharmaceuticals were associated with sex and ethnicity (Sowinski et al. 1996) and different 
authors found gender-specific responses in fish too (Giltrow et al. 2009; Sun et al. 2015). 
 
Population relevant endpoints as well as gene expression analyses of gonadotropins and 
detoxification enzymes were the initial focus of this work. Evaluating the endocrine 
disruption potential of the substances based on VTG gene expression was added. Since at 
least DCF very likely acts as an EDC, possessing an estrogenic mode of action, future 
research should focus on sex differentiation, gonadal steroidogenesis, reproductive success 
and behavioral impacts, e.g. on mating behavior. Additionally, reproductive endpoints such as 
egg production are especially interesting when studying the effects of ß-blockers, since the 
reproductive toxicity associated might be highly modified by the physicochemical properties 
of these compounds, ranging from being very lipophilic to hydrophilic (Overturf et al. 2015). 
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Furthermore, for ß-blockers, behavior effects should be studied. Owen et al. (2007) already 
stated that ß-blockers might decrease neural activity in the brain causing abnormal activity 
rhythms or sleeping and breeding cycles. Furthermore, since pharmaceuticals can act in fish 
in a similar mode than in mammals, potential side effects such as kidney failure and intestinal 
pathology should be considered in the future.  
 
Another very interesting approach that should gain more attention is to study the effects of 
substance mixtures and pharmaceutical exposure combined with other stressors that likely 
occur in nature. The adrenergic system in fish is particularly important during stress 
(Wendelaar-Bonga 1997) and certain ß-blockers interfere with the normal physiological 
functioning. Therefore, the ability of fish to deal with a stressor in the presence of or after a 
long-term exposure to pharmaceuticals, especially ß-blockers, would be insightful. It is very 
likely that the stress response would be altered. Certain processes such as the ability to 
mobilize energy resources as well as the ability to take up and deliver oxygen to the tissues 
and adjustments of the heart rate and vascular resistance could change with ß-blockade 
because the involved tissues (or cells) possess ß-ARs. Hence, the survival of the fish could be 
threatened given the inability to generate the "fight-or-flight" response (Massarsky et al. 
2011).    
 
Last but not least, the reversibility of the physiological responses due to pharmaceutical 
exposure should be examined as done e.g. by Baumann et al. (2014). If the effects would be 
reversed after a recovery time this would count for an additional incentive to find solutions to 
eliminate xenobiotics from surface waters especially threatened or were adverse impacts on 
the aquatic organisms were already detected.  
 
Derived from the results presented, the greatest threat of DCF seems to be its potential to act 
as an estrogenic endocrine disruptor. For MTP the risk for fish health seems to be low. 
Mixture effects or effects in combination with other stressors occurring in the aquatic 
environment most likely lead to a different outcome though, since β-blockers compete for the 
receptor site of the endogenous catecholamines.  
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7 Annex 
7.1 DCF measured with LC- QTOF 
UPLC parameters:  
column: Agilent Eclipse Plus C18  2.1 x 50 mm ; 1.8 µm pore size 
 
solvents: 
A: H2O + 0.1 % formic acid 
B: acetonitrile  + 0.1 % formic acid 
gradient: flow rate 400 µl min
-1
 
 
Time (min) A % B % 
0 80 20 
10 20 80 
11 80 20 
12 80 20 
 
injection volumen  1 µL 
oven temperature: 30 °C 
retention time: 1.5 min 
 
QTOF parameters: 
general:  
 MRM mode: positive 
 ion Source Dual AJS ESI 
QTOF MS mode mass range 100-1500 m/z 
 
mass DCF : 
DCF M (H+) = 296,0240  
 
hardware :  
UPLC : Agilent 1290 Infinity 
QTOF : Agilent 6550 iFunnel QTOF LC/MS 
 
software : Agilent Mass Hunter workstation Data Acquisition  
       Agilent Mass Hunter Qualitative Analysis B.06.00 
       Agilent Mass Hunter Quantitative Analysis B.06.00 
 
Limit of detection and limit of quantitation were 1 ng mL
-1
 and 25 ng mL
-1
, respectively. 
Calibration was linear (R2=) between 25 and 250 ng mL
-1
. 
 
 
 
 
 
 
 
  Annex 
101 
 
7.2 MTP measured with LC- QTOF 
UPLC- parameters:  
column: Agilent Eclipse Plus C18  2.1x50 mm ; 1.8 µm pore size 
 
solvents: 
A: H2O + 0.1 % formic acid 
B: acetonitril + 0.1 % formic acid 
gradient: flow rate 400 µl min
-1
 
 
Time (min) A % B % 
0 95 5 
2 20 80 
3 95 5 
5 95 5 
 
injection volumen 1 µL 
column temperature: 20 °C 
retention time: 1.5 min 
 
QTOF Parameters: 
general:  
 positive 
 Ion Source Dual AJS ESI 
QTOF MS Mode Mass Range 100-1500 m/z 
 
mass MTP : 
MTP M (H+) = 268,1908  
 
hardware :  
UPLC : Agilent 1290 Infinity 
QTOF : Agilent 6550 iFunnel QTOF LC/MS 
 
software : Agilent Mass Hunter workstation Data Acquisition  
       Agilent Mass Hunter Qualitative Analysis B.06.00 
       Agilent Mass Hunter Quantitative Analysis B.06.00 
 
Limit of detection and limit of quantitation were 0.2 ng mL
-1
and 1 ng mL
-1
, respectively. 
Calibration was linear (R2=) between 1 and 100 ng mL
-1
. 
 
  
 
 
